<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1004257228
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        WELLBUTRIN XL 150 EXTENDED RELEASE F.C.TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BUPROPION HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        150
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Prolonged-release film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        65.00
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Bausch Health Companies Inc" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Bausch Health Companies Inc
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Glaxo Saudi Arabia Ltd.
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N06AX12
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Wellbutrin belongs to a group of medicines called anti-depressants. It is used to treat depression.</p><p>Wellbutrin works by affecting two chemicals in the brain that are believed to help regulate your mood (<em>dopamine </em>and<em> noradrenaline</em>).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Don&rsquo;t take Wellbutrin<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_e8965d51-a874-46d9-8a58-a6b4a5c09aaa \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]-->XL</p><p>&Yuml;&nbsp; if you are<strong> allergic</strong> (<em>hypersensitive</em>) to bupropion, or any of the other ingredients in Wellbutrin XL (<em>listed in Section 6</em>)</p><p>&Yuml;&nbsp; if you have a condition that causes<strong> fits</strong>, such as <strong>epilepsy.</strong></p><p>&Yuml;&nbsp; if you are usually a<strong> heavy drinker</strong> and you have just stopped drinking alcohol, or are going to stop while you&rsquo;re taking Wellbutrin XL</p><p>&Yuml;&nbsp; if you have<strong> recently stopped taking sedatives</strong>, or if you are going to stop them while you&rsquo;re taking Wellbutrin XL</p><p>&Yuml;&nbsp; if you are taking any <strong>other medicines which contain bupropion </strong>(such as<strong> </strong>Wellbutrin XL, to stop smoking)</p><p>&Yuml;&nbsp; if you have an<strong> eating disorder</strong>, or had one in the past (for example, bulimia or anorexia nervosa)</p><p>&Yuml;&nbsp; if you are taking<strong> other medicines for depression</strong> or <strong>Parkinson&rsquo;s disease</strong> called <em>monoamine oxidase inhibitors</em> <em>(MAOIs)</em>, or have taken them in the last 14 days.</p><p>&Yuml;&nbsp; &nbsp;If you have a condition called <strong>Brugada syndrome</strong> (a rare hereditary syndrome that affects the heart rhythm) or if cardiac arrest or sudden death occurred in your family.</p><p>&nbsp;</p><p>&egrave;&nbsp;&nbsp; If any of these applies to you,<strong> don&rsquo;t take Wellbutrin XL</strong> until you have checked with your doctor.</p><p>Take special care with Wellbutrin<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_91773af2-80fe-457f-9787-5c7eb935733b \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]-->XL</p><p><strong>Wellbutrin XL is not recommended for people under 18</strong> <strong>years</strong> because it has not been adequately studied in these patients. When people aged under 18 years take anti-depressants, they have a higher risk of suicidal thoughts and behaviour.</p><p><strong>Your doctor needs to know certain information before you start taking Wellbutrin XL</strong>. This is because some conditions make it more likely that you will have side effects <em>(see also &lsquo;Possible side effects&rsquo; in Section 4)</em>. If any of these conditions applies to you, your doctor will monitor you more closely while you are taking Wellbutrin XL or recommend another treatment.</p><p><strong>Fits (seizures)</strong></p><p>Wellbutrin XL has been shown to cause fits (<em>seizures</em>) in about 1 in 1000 people (<em>see<strong> </strong>also &lsquo;Taking other medicines&rsquo; in this section and &lsquo;Possible side effects&rsquo; in Section 4</em>).</p><p>Fits are more likely:</p><p>&Yuml;&nbsp; if you regularly drink <strong>a lot of alcohol</strong></p><p>&Yuml;&nbsp; if you regularly take<strong> sedatives</strong></p><p>&Yuml;&nbsp; if you have<strong> diabetes</strong></p><p>&Yuml;&nbsp; if you take<strong> stimulants</strong> or other medicines to control your <strong>weight </strong>or<strong> appetite</strong></p><p>&Yuml;&nbsp; if you have a<strong> brain tumour</strong></p><p>&Yuml;&nbsp; if you have a<strong> history of fits</strong></p><p>&Yuml;&nbsp; if you have ever had a <strong>serious head injury</strong></p><p>&Yuml;&nbsp; if you take medicines that are known <strong>to increase the chance of having a fit</strong></p><p>If you have a fit during treatment:</p><p>&egrave;&nbsp;&nbsp; <strong>Stop taking Wellbutrin XL and don&rsquo;t take any more. Contact your doctor for advice</strong>.</p><p><strong>Bipolar disorder (extreme mood swings)</strong></p><p>If you have bipolar disorder, Wellbutrin XL could bring on an episode of this illness.</p><p>&egrave;&nbsp;&nbsp; <strong>Contact your doctor</strong> for advice if this happens to you.</p><p><strong>You may have more risk of side effects:</strong></p><p>&Yuml;&nbsp; if you have <strong>kidney or liver problems</strong></p><p>&Yuml;&nbsp; if you are <strong>aged over 65</strong></p><p><strong>Tell your doctor or pharmacist if either of these applies to you. </strong>You may need to take a lower dosage and be checked more closely while you are taking Wellbutrin XL (<em>see &lsquo;</em><em>How to take Wellbutrin XL&rsquo; in Section 3</em>).</p><p><strong>Thoughts of suicide or worsening of your condition</strong></p><p>People who are depressed can sometimes have thoughts of harming or killing themselves. These thoughts may be increased when first starting anti-depressants. These medicines all take time to have their full effect - sometimes weeks.</p><p>You may be more likely to think like this:</p><p>&Yuml;&nbsp; if you have previously had thoughts about harming or killing yourself</p><p>&Yuml;&nbsp; if you are under 25 years old</p><p>If you have thoughts of harming or killing yourself at any time:</p><p>&egrave;&nbsp;&nbsp; <strong>Contact your doctor</strong> or go to a hospital straight away</p><p><strong>You may find it helpful to tell a relative or close friend</strong> that you are depressed and ask them to read this leaflet. You might ask them to tell you if they think your depression is getting worse, or if they are worried about changes in your behaviour.</p><p><strong>High blood pressure and Wellbutrin XL</strong></p><p>Some people taking Wellbutrin XL have a rise in blood pressure which needs treatment. If you already have high blood pressure, it can become worse. This is more likely if you&rsquo;re using <strong>nicotine patches</strong> to help you stop smoking.</p><p>&egrave; <strong>Tell your doctor</strong> if you have a history of high blood pressure.</p><p>Other medicines and Wellbutrin<!--[if supportFields]><span style='font-family:"Times New Roman",serif;
mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_ab1f299b-fca7-4f2e-b18b-12249776ff30 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]-->XL</p><p><strong>Tell your doctor or pharmacist if you&rsquo;re taking any other medicines, if you&rsquo;ve taken any recently, or if you start taking new ones,</strong> including medicines you bought without a prescription.</p><p>There may be a higher than usual risk of fits if you take (<em>see also &lsquo;Fits (seizures)&rsquo; earlier in this section</em>):<!--[if supportFields]><span
style='mso-bidi-font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi;font-weight:normal;mso-bidi-font-weight:bold'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_33e73706-63d0-40f0-8c24-1e4214843600 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='mso-bidi-font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi;font-weight:normal;mso-bidi-font-weight:bold'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>&Yuml;&nbsp; <strong>stimulants</strong> or other medicines to control your <strong>weight </strong>or<strong> appetite.</strong></p><p>&Yuml;&nbsp; medicines for<strong> diabetes</strong>.</p><p>&egrave;&nbsp;&nbsp; <strong>If you take any medicines in this list, talk to your doctor straight away</strong>, before you take Wellbutrin XL</p><p><strong>There may be a higher than usual risk of other side effects or other problems if you take </strong>(<em>see also &lsquo;Don&rsquo;t take Wellbutrin XL&rsquo; in Section 2</em>):</p><p>&Yuml;&nbsp; other medicines for<strong> depression </strong>or <strong>other mental health problems</strong> (such as desipramine or selective serotonin reuptake inhibitors (SSRIs))</p><p>&Yuml;&nbsp; medicines for<strong> Parkinson&rsquo;s disease</strong> (such as levodopa, amantadine or orphenadrine)</p><p>&Yuml;&nbsp; <strong>carbamazepine</strong>,<strong> phenobarbital</strong>, <strong>phenytoin,</strong> to treat <strong>epilepsy</strong> or some <strong>mental health problems.</strong></p><p>&Yuml;&nbsp; some medicines used to treat <strong>cancer </strong>(such as cyclophosphamide, ifosphamide or tamoxifen)</p><p>&Yuml;&nbsp; <strong>ticlopidine</strong> or <strong>clopidogrel</strong>, mainly used to treat <strong>heart disease</strong> or <strong>stroke.</strong></p><p>&Yuml;&nbsp; some <strong>beta blockers</strong>, mainly used to treat high blood pressure.</p><p>&Yuml;&nbsp; some medicines for<strong> irregular heart rhythm </strong></p><p>&Yuml;&nbsp; <strong>ritonavir </strong>or<strong> efavirenz</strong>, medicines to treat HIV infection.</p><p>&Yuml;&nbsp; <strong>nicotine replacement patches </strong>(<em>see &lsquo;High blood pressure and Wellbutrin XL&rsquo; in section 2</em>)</p><p>&egrave;&nbsp;&nbsp; <strong>Tell your doctor or pharmacist if you are taking any of these.</strong></p><p><strong>Alcohol and Wellbutrin XL</strong></p><p>Some people find they are more sensitive to alcohol while taking Wellbutrin XL. Your doctor may suggest you don&rsquo;t drink alcohol while you&rsquo;re taking Wellbutrin XL, or try to drink as little as possible.</p><p>Laboratory tests<!--[if supportFields]><span style='font-family:
"Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
major-bidi;mso-bidi-theme-font:major-bidi;mso-bidi-font-weight:bold'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_7afc54a5-5c75-4b58-a708-2608feec3802 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-bidi-font-weight:
bold'><span style='mso-element:field-end'></span></span><![endif]--></p><p>Wellbutrin XL may interfere with some laboratory tests to detect other drugs. If you require a laboratory test, tell your doctor or hospital that you are taking Wellbutrin XL.</p><p>Pregnancy and breast-feeding<!--[if supportFields]><span style='font-family:"Times New Roman",serif;
mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_7d55cd0a-5f1d-4408-95a5-4b82110c442e \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>If you are<strong> pregnant,</strong> or <strong>think you could be, </strong>or if you are <strong>planning to become pregnant don&rsquo;t take Wellbutrin XL</strong> without checking with your doctor. Your doctor<strong> </strong>will consider the benefit to you and the risk to your baby of taking Wellbutrin XL while you&#39;re pregnant.&nbsp; Some, but not all studies have reported an increase in the risk of birth defects, particularly heart defects, in babies whose mothers were taking Wellbutrin XL. It is not known if these are due to the use of Wellbutrin XL.&nbsp;</p><p><strong>Breast feeding is not recommended </strong>during treatment with Wellbutrin XL. The ingredients can pass into your breast milk, and so may harm your baby. Talk to your doctor about this.</p><p>Driving and using machines<!--[if supportFields]><span style='font-family:"Times New Roman",serif;
mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_c6260ed5-6467-4e39-b3c0-9b9e57fec6bc \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>Wellbutrin XL may affect your ability to drive and use machines.</p><p><strong>Don&rsquo;t drive or use machines</strong> unless you are sure you&rsquo;re not affected</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Always take Wellbutrin XL exactly as your doctor has told you to</strong>. Check with your doctor or pharmacist if you are not sure.</p><p>How much to take<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_77cffd8a-1eb8-42e6-bdcd-d4ed4c0569c9 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-end'></span></span><![endif]--></p><p><strong>The usual starting dose </strong>is one 150 mg tablet once a day.</p><p><strong>Your doctor may increase your dose to 300&nbsp;mg </strong>once a day if your depression does not improve after several weeks. If there is still no improvement after several more weeks, your dose may be increased to a maximum of 450&nbsp;mg once a day.</p><p>Take your dose of Wellbutrin XL in the morning. Leave at least 24 hours between doses. <strong>Don&#39;t take Wellbutrin XL more than once each day. </strong></p><p>The tablet is covered by a shell that slowly releases medicine inside your body. You may notice something in your stool that looks like a tablet. This is normal. This is the empty shell passing from your body.</p><p><strong>Some people may need to take a lower dose of Wellbutrin XL</strong> to reduce the risk of side effects:</p><p>&Yuml;&nbsp; if you are aged over 65</p><p>&Yuml;&nbsp; if you have liver or kidney disease</p><p><strong>Tell your doctor or pharmacist if either of these applies to you.</strong></p><p>How to take your tablets<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_a212e528-408c-4c4f-ba10-1b59990b9266 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-end'></span></span><![endif]--></p><p><strong>Swallow your Wellbutrin XL tablets whole</strong>. <strong>Don&rsquo;t chew, crush, or split them</strong> &mdash; if you do, the medicine will be released into your body too quickly. This will make you more likely to have side effects, including fits.</p><p>How long to take Wellbutrin XL for<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_46ea1164-0e5b-4de4-8f32-22055cbc7442 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-end'></span></span><![endif]--></p><p><strong>Don&rsquo;t take any more Wellbutrin XL than your doctor has recommended</strong>. It takes time for the medicine to have its full effect, sometimes weeks.</p><p><strong>Talk to your doctor regularly</strong> to decide how long you should carry on taking Wellbutrin XL. When you feel better, your doctor may advise you to keep taking it to stop your depression coming back.</p><p>If you forget to take Wellbutrin XL<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_f882ccc9-e16b-4286-be8e-863f06262424 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-end'></span></span><![endif]--></p><p><strong>Don&rsquo;t take extra tablets to make up for a missed dose.</strong> Just take your next tablet at the usual time.</p><p>If you take too much Wellbutrin<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_93e40461-e76b-467b-bec2-6bb9105f2322 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-end'></span></span><![endif]-->XL</p><p>Don&rsquo;t take more tablets than your doctor has recommended. If you take too many tablets of Wellbutrin XL, you may be <strong>more likely to have side effects, including fits</strong>.</p><p>&egrave;&nbsp;&nbsp;&nbsp; <strong>Don&rsquo;t delay. Contact your doctor or your nearest hospital emergency department immediately</strong>. If possible, show them the Wellbutrin XL pack.</p><p>Don&rsquo;t stop Wellbutrin XL without advice<!--[if supportFields]><span
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi;mso-fareast-language:EN-US'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_3b834194-9bb3-4a05-b580-af49f1f71d5a \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi;mso-fareast-language:EN-US'><span style='mso-element:field-end'></span></span><![endif]--></p><p><strong>Don&rsquo;t stop taking Wellbutrin XL unless your doctor tells you to. </strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Wellbutrin XL can cause side effects, but not everyone gets them.</p><p><strong>Fits (seizures)</strong></p><p>Fits may occur in approximately 1 in every 1000 people taking Wellbutrin XL.</p><p><strong>Symptoms of a fit</strong> include convulsions, and usually loss of consciousness. Someone who has had a fit may be confused afterwards and may not remember what has happened.</p><p>Fits are more likely if you take too much Wellbutrin XL, if you take some other medicines, or if you are at higher than usual risk of fits (<em>see &lsquo;Take special care with Wellbutrin XL&rsquo;</em><em> in</em><em> Section 2</em>).</p><p>&egrave;&nbsp;&nbsp; <strong>If you have a fit</strong>, <strong>don&rsquo;t take any more Wellbutrin XL tablets. Contact your doctor when you have recovered.</strong></p><p><strong>Severe allergic reactions</strong></p><p>Very rarely (up to 1 in 10000) people may have potentially serious allergic reactions to Wellbutrin XL. Signs of allergic reactions include:</p><p>&Yuml;&nbsp; skin rash which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge &ndash; <em>erythema multiforme</em>)</p><p>&Yuml;&nbsp; a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes, and genitals (<em>Stevens-Johnson syndrome</em>)</p><p>&Yuml;&nbsp; unusual wheezing, or difficulty in breathing</p><p>&Yuml;&nbsp; swollen eyelids, lips, or tongue</p><p>&Yuml;&nbsp; pains in muscles or joints</p><p>&Yuml;&nbsp; collapse or blackout</p><p>&egrave;&nbsp;&nbsp; <strong>If you have any signs of an allergic reaction, don&rsquo;t take any more Wellbutrin XL tablets. Contact your doctor immediately.</strong></p><p><strong>Lupus skin rash or worsening of lupus symptoms.</strong></p><p>Lupus is an immune system disorder affecting the skin and other organs. Very rarely (up to 1 in 10,000) people may experience lupus skin rash or worsening of lupus symptoms while taking Wellbutrin XL. Symptoms include:</p><p>&Yuml;&nbsp; lupus flares</p><p>&Yuml;&nbsp; skin rash or lesions (particularly on sun-exposed areas)</p><p>&egrave;&nbsp;&nbsp; <strong>If you experience lupus skin rash or worsening of lupus symptoms contact your doctor straight away, as it might be necessary to stop the treatment.</strong></p><p>Very common side effects<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_3e6f869b-307d-4e36-a366-b09ed7bf678c \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-end'></span></span><![endif]--></p><p>These may affect <strong>more than 1 in 10</strong> people:</p><p>&Yuml;&nbsp; difficulty in sleeping (insomnia)</p><p>&Yuml;&nbsp; headache, dry mouth</p><p>&Yuml;&nbsp; feeling sick (nausea), being sick (vomiting)</p><p>Common side effects<!--[if supportFields]><span style='font-family:
"Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:EN-US'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_5ea59531-1e6f-484a-b047-00b28c1ec214 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-end'></span></span><![endif]--></p><p>These may affect <strong>up to 1 in 10</strong> people:</p><p>&Yuml;&nbsp; fever, dizziness, sweating, skin rash (sometimes due to an allergic reaction), itching.</p><p>&Yuml;&nbsp; feeling shaky (tremor), feeling weak, chest pain</p><p>&Yuml;&nbsp; feeling anxious or agitated, stomach pain, constipation, changes in the taste of food, loss of appetite (<em>anorexia</em>)</p><p>&Yuml;&nbsp; increase in blood pressure (sometimes severe), flushing.</p><p>&Yuml;&nbsp; persistent noise in the ears (<em>tinnitus</em>), visual disturbances</p><p>&nbsp;Uncommon side effects<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_16f43c7e-5ae7-498b-8bf1-620008b23aa6 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-end'></span></span><![endif]--></p><p>These may affect <strong>up to 1 in 100</strong> people:</p><p>&Yuml;&nbsp; feeling depressed (<em>see also &lsquo;Take special care with Wellbutrin XL&rsquo; in Section 2</em>)</p><p>&Yuml;&nbsp; feeling confused</p><p>&Yuml;&nbsp; difficulty concentrating</p><p>&Yuml;&nbsp; rapid heartbeat</p><p>&Yuml;&nbsp; weight loss</p><p>Rare side effects<!--[if supportFields]><span style='font-family:
"Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:EN-US'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_59a2935e-91b6-43bf-bd1f-e42446cdda3d \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-end'></span></span><![endif]--></p><p>These may affect <strong>up to 1 in 1,000</strong> people:</p><p>&Yuml;&nbsp; fits (<em>see the beginning of this section</em>)</p><p>Very rare side effects<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_d67798ce-0649-4dd3-81e2-1d1e51c44542 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-fareast-language:
EN-US'><span style='mso-element:field-end'></span></span><![endif]--></p><p>These may affect <strong>up to 1 in 10,000</strong> people:</p><p>&Yuml;&nbsp; severe allergic reactions (<em>see the beginning of this section</em>)</p><p>&Yuml;&nbsp; lupus skin rash or worsening of lupus symptoms (see the beginning of this section)</p><p>&Yuml;&nbsp; rash with pus filled pimples/blisters (acute generalised exanthematous pustulosis)</p><p>&Yuml;&nbsp; unusual hair loss or thinning (alopecia).</p><p>&Yuml;&nbsp; feeling aggressive, hostile, irritable, or restless, strange dreams</p><p>&Yuml;&nbsp; seeing or hearing things that are not there (<em>hallucinations</em>), feeling unreal or strange (<em>depersonalisation</em>), sensing or believing things that are not true (<em>delusions</em>), severe suspiciousness (<em>paranoia</em>), feeling of panic (panic attack)</p><p>&Yuml;&nbsp; loss of memory</p><p>&Yuml;&nbsp; twitching, uncontrollable muscle spasms, uncontrolled movements, problems with walking or coordination (<em>ataxia</em>)</p><p>&Yuml;&nbsp; stuttering</p><p>&Yuml;&nbsp; tingling or numbness</p><p>&Yuml;&nbsp; fainting, feeling faint when you stand up suddenly, because your blood pressure falls.</p><p>&Yuml;&nbsp; fast or irregular heartbeats (<em>palpitations</em>)</p><p>&Yuml;&nbsp; urinating (passing water) more or less than usual.</p><p>&Yuml;&nbsp; urinary incontinence (involuntary urination, leakage of urine)</p><p>&Yuml;&nbsp; your skin or the whites of your eyes turning yellow (<em>jaundice</em>), inflammation of the liver (<em>hepatitis</em>)</p><p>&Yuml;&nbsp; widening of blood vessels (vasodilatation).</p><p>&nbsp;</p><p>Very rare side effects which may show up in blood tests:</p><p>&Yuml;&nbsp; increase in levels of liver enzymes.</p><p>&Yuml;&nbsp; changes in blood sugar levels</p><p>&Yuml;&nbsp; decrease in blood sodium (hyponatraemia)</p><p>&nbsp;</p><p><strong>Tell your doctor or pharmacist</strong> if any of the side effects becomes <strong>severe or troublesome</strong>, or if you notice any side effects not listed in this leaflet</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]--></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Keep out of the reach and sight of children.</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use Wellbutrin XL after the expiry date which is stated on the pack. The expiry date refers to the last day of that month.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store Wellbutrin XL below 25&deg;C, store in dry place</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store in the original package to protect from humidity and light.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The bottle contains a small, sealed canister containing charcoal and silica gel, to keep the tablets dry. Keep the canister in the bottle. Don&rsquo;t swallow it.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Don&rsquo;t dispose of medicines in wastewater or household waste.&nbsp; Ask your pharmacist how to dispose of medicines no longer required. This will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Wellbutrin XL contains<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-bidi-font-weight:
bold'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_21fdd016-4111-4a5f-a231-d74d3395f51b \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-bidi-font-weight:
bold'><span style='mso-element:field-end'></span></span><![endif]--></p><p>The active substance is bupropion hydrochloride. Wellbutrin XL tablets come in different strengths.</p><p>Each tablet of Wellbutrin XL contains either:</p><p>150 or 300&nbsp;mg bupropion hydrochloride</p><p><strong>&nbsp;</strong></p><p><strong>The other ingredients are: </strong></p><p><strong>Tablet Core </strong></p><p>Polyvinyl alcohol</p><p>Glyceryl behenate</p><p>&nbsp;</p><p><strong>Tablet Coat</strong></p><p>Ethyl cellulose 100</p><p>Polyethylene glycol 1450</p><p>Povidone</p><p>Methacrylic acid copolymer dispersion (Eudragit L30 D-55)</p><p>Silicon dioxide</p><p>Triethyl citrate</p><p>Edible black ink (for printing)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Wellbutrin XL looks like and contents of the pack 
White opaque high-density polyethylene (HDPE) bottles containing a combination charcoal/silica gel desiccant canister and closed with a child-resistant closure that includes an induction heat seal membrane.
150 mg: 30 tablets
300 mg: 30 tablets

Not all presentations are available in every country.

WELLBUTRIN XL is a trademark owned by or licensed the GSK group of companies.
© 2024 GSK group of companies. All Rights Reserved.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufactured by:</strong></p><p>Bausch Health Companies Inc.</p><p>Manufacturing Division, 100 Life Sciences Parkway, Steinbach, MB, Canada R5G 1Z7</p><p><strong>&nbsp;</strong></p><p><strong>Packed by:</strong></p><p>Glaxo Wellcome S.A.*, Aranda, Spain</p><p><strong>Marketing Authorization Holder:</strong></p><p>Glaxo Saudi Arabia Ltd.*, Jeddah, Kingdom of Saudi Arabia</p><p>*member of GSK group of companies</p><p><strong>&nbsp;</strong></p><p><strong>For any information about this medicinal product, please contact: </strong></p><p><strong>-GSK - Head Office, Jeddah </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel: +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile : +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email : <u>&nbsp;</u>gcc.medinfo@gsk.com</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                GDS Version Number: GDS35
Date of issue: 07 June 2024

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ينتمي ويلبيترين أكس أل إلى مجموعة من الأدوية يُطلق عليها مضادات الاكتئاب. فهو يستخدم لعلاج الاكتئاب.</p><p dir="RTL">يعمل ويلبيترين أكس أل عن طريق التأثير على مادتين كيميائيتين في الدماغ يُعتقد أنهما تساعدان على تنظيم الحالة المزاجية <em>(الدوبامين والنورادرينالين)</em>.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا تتناول ويلبيترين أكس أل <!--[if supportFields]><span
lang=AR-SA style='font-size:14.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-begin'></span><span style='mso-spacerun:yes'> </span></span><span
dir=LTR style='font-size:14.0pt;font-family:"Traditional Arabic",serif;
font-weight:normal;mso-bidi-font-weight:bold'>DOCVARIABLE</span><span dir=RTL></span><span
dir=RTL></span><span style='font-size:14.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='font-size:14.0pt;font-family:"Traditional Arabic",serif;
font-weight:normal;mso-bidi-font-weight:bold'>VAULT_ND_b29fa435-62f5-46d6-95b3-ff4737ca8000
\* MERGEFORMAT</span><span dir=RTL></span><span dir=RTL></span><span
style='font-size:14.0pt;font-family:"Traditional Arabic",serif;mso-ansi-font-weight:
normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span dir=RTL></span> <span
lang=AR-SA><span style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='font-size:14.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL"><em>&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; </em>في حالة وجود <strong>حساسية</strong> <em>(فرط الحساسية)</em> لبوپروپيون، أو أي من المكونات الأخرى في ويلبيترين أكس أل <em>(المدرجة في القسم </em><em>6</em><em>)</em></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بحالة تسبب <strong>نوبات</strong>، مثل <strong>الصرع</strong></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت معتادًا على <strong>الإفراط في الشراب</strong> وتوقفت لتوِّك عن شرب الكحوليات أو تنوي التوقف أثناء تناول ويلبيترين أكس أل</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد <strong>توقفت مؤخرًا عن تناول المهدئات</strong>، أو تنوي التوقف عن تناولها أثناء تناول ويلبيترين أكس أل</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول أي <strong>أدوية أخرى تحتوي على بوپروپيون</strong> (مثل ويلبيترين أكس أل، للإقلاع عن التدخين)</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من <strong>اضطرابات في الأكل</strong>، أو كنت تعاني من أي منها فيما مضى (على سبيل المثال، النهام العصبي أو فقدان الشهية العصبي)</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول <strong>أدوية أخرى لعلاج الاكتئاب</strong> أو <strong>مرض باركنسون</strong> تسمى &rlm;‫<em>مثبطات أوكسيديز أحادي الأمين</em> (<em> </em><em>MAOI</em>) ، أو تناولتها خلال آخر 14 يومًا</p><p dir="RTL"><strong>&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>متلازمة بروغادا</strong></p><p dir="RTL">إذا كنت تعاني من حالة تسمى متلازمة بروغادا (متلازمة وراثية نادرة تؤثر على النظم القلبي) أو في حالة وجود تاريخ عائلي للسكتة</p><p dir="RTL">القلبية أو الموت المفاجئ.</p><p dir="RTL">&ccedil;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كانت أي حالة من هذه الحالات تنطبق عليك، <strong>فلا تتناول ويلبيترين أكس أل</strong> إلا بعد استشارة الطبيب</p><p dir="RTL">توخَ الحذر البالغ عند استعمال ويلبيترين أكس أل <!--[if supportFields]><span
lang=AR-SA style='font-size:14.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-begin'></span><span style='mso-spacerun:yes'> </span></span><span
dir=LTR style='font-size:14.0pt;font-family:"Traditional Arabic",serif;
font-weight:normal;mso-bidi-font-weight:bold'>DOCVARIABLE</span><span dir=RTL></span><span
dir=RTL></span><span style='font-size:14.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='font-size:14.0pt;font-family:"Traditional Arabic",serif;
font-weight:normal;mso-bidi-font-weight:bold'>VAULT_ND_199828ee-2e2e-4d21-a5fb-669527c4b827
\* MERGEFORMAT</span><span dir=RTL></span><span dir=RTL></span><span
style='font-size:14.0pt;font-family:"Traditional Arabic",serif;mso-ansi-font-weight:
normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span dir=RTL></span> <span
lang=AR-SA><span style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='font-size:14.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL"><strong>لا يُنصح بتناول ويلبيترين أكس أل للأشخاص الذين تقل أعمارهم عن </strong><strong>18</strong><strong> عامًا</strong>، حيث لم تتم دراسته بشكلٍ كافٍ على هذه الفئة من المرضى. عندما يتناول الأشخاص الذين تقل أعمارهم عن 18 عامًا العقاقير المضادة للاكتئاب، تزيد لديهم خطورة ظهور ميول وسلوك انتحاري.</p><p dir="RTL"><strong>يحتاج طبيبك إلى معرفة معلومات معينة قبل البدء في تناول ويلبيترين أكس أل</strong>.<strong> </strong>وذلك لأن بعض الحالات تزيد من احتمالية ظهور آثار جانبية <em>(انظر أيضًا &quot;الآثار الجانبية المحتملة&quot; في القسم </em><em>4</em><em>)</em>. إذا كانت أي حالة من هذه الحالات تنطبق عليك، فسوف يتابعك طبيبك عن كثب وأنت تتناول ويلبيترين أكس أل ، أو يوصي بعلاج آخر.</p><p dir="RTL"><strong>النوبات (التشنجات)</strong></p><p dir="RTL">لقد ثبت أن ويلبيترين أكس أل يسبب نوبات <em>(تشنجات)</em> لشخص واحد بين كل 1000 شخص <em>(انظر أيضًا &quot;تناول الأدوية الأخرى&quot; في هذا القسم و&quot;</em><em>&rlm;</em>‫<em>الآثار الجانبية المحتملة&quot; في القسم </em><em>4</em><em>)</em>.</p><p dir="RTL">يكون من الأرجح ظهور النوبات:</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت معتادًا على شرب <strong>الكثير من الكحوليات</strong></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت معتادًا على تناول <strong>المهدئات</strong></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بمرض <strong>السكري</strong></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول<strong> منشطات</strong> أو أدوية أخرى للتحكم في <strong>وزنك</strong> أو <strong>شهيتك</strong></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا <strong>بورم في المخ</strong></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك <strong>تاريخ مرضي من الإصابة بالنوبات</strong></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا تعرضت في أي وقت <strong>لإصابة خطيرة في الرأس</strong></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول أدوية تُعرف بتسببها <strong>في زيادة فرص حدوث النوبات </strong></p><p dir="RTL">إذا تعرضت لنوبة أثناء العلاج:</p><p dir="RTL"><strong>&ccedil;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>توقف عن تناول ويلبيترين أكس أل ولا تتناول المزيد منه. اتصل بطبيبك للحصول على مشورة.</strong></p><p dir="RTL"><strong>&rlm;</strong>‫<strong>الاضطراب ثنائي القطب</strong><strong>&rlm;</strong>‫<strong> (التقلبات المزاجية الشديدة)</strong></p><p dir="RTL">إذا كنت مصابًا بالاضطراب ثنائي القطب، يمكن أن يؤدي ويلبيترين أكس أل إلى حدوث نوبة من هذا المرض.</p><p dir="RTL">&ccedil;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>اتصل بطبيبك</strong> للحصول على مشورة إذا تعرضت لهذا الأمر.</p><p dir="RTL"><strong>قد تتعرض لزيادة مخاطر الإصابة بالآثار الجانبية:</strong></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من <strong>مشكلات في الكلى أو الكبد</strong></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان عمرك <strong>يزيد عن </strong><strong>65</strong><strong> عامًا</strong></p><p dir="RTL"><strong>أبلغ الطبيب أو الصيدلاني إذا كانت أي من هذه الحالات تنطبق عليك. </strong>قد تحتاج إلى تناول جرعة أقل والخضوع لمتابعة وفحص عن كثب أكبر أثناء تناول ويلبيترين أكس أل <em>(انظر &quot;كيفية تناول</em> <em>ويلبيترين أكس أل &quot; في القسم </em><em>3</em><em>)</em>.</p><p dir="RTL"><strong>الأفكار الانتحارية أو تفاقم حالتك</strong></p><p dir="RTL">يمكن أن تراود الأشخاص المصابين بالاكتئاب في بعض الأحيان أفكار بإيذاء أنفسهم أو بالانتحار. ويمكن أن تزيد هذه الأفكار عند بدء العلاج بالعقاقير المضادة للاكتئاب لأول مرة. وتستغرق هذه الأدوية وقتًا حتى يظهر تأثيرها بالكامل، وقد يستغرق ذلك أسابيع أحيانًا.</p><p dir="RTL">يكون من الأرجح أن تفكر بهذا الشكل:</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا راودتك أفكار فيما سبق بإيذاء نفسك أو بالانتحار</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان عمرك أقل من 25 عامًا</p><p dir="RTL">إذا راودتك أفكار في أي وقت بإيذاء نفسك أو بالانتحار:</p><p dir="RTL">&ccedil;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>اتصل بطبيبك</strong> أو اذهب إلى المستشفى على الفور</p><p dir="RTL"><strong>قد تجد أنه من المفيد أن تخبر أحد أقاربك أو أصدقائك المقربين</strong> أنك مكتئب، وتطلب منهم قراءة هذه النشرة. ويمكن أن تطلب منهم أن يخبروك إذا شعروا أن حالة الاكتئاب تزداد سوءًا لديك، أو إذا شعروا بالقلق من التغيرات التي طرأت على سلوكياتك.</p><p dir="RTL"><strong>ارتفاع ضغط الدم وويلبيترين أكس أل</strong></p><p dir="RTL">يصاب بعض الأشخاص الذين يتناولون ويلبيترين أكس أل بارتفاع في ضغط الدم، مما يستلزم علاجًا. إذا كنت تعاني بالفعل من ارتفاع في ضغط الدم، يمكن أن تزداد الحالة سوءًا. ومن الأرجح أن يحدث هذا إذا كنت تستخدم <strong>لصقات النيكوتين</strong> لمساعدتك على الإقلاع عن التدخين.</p><p dir="RTL">&ccedil;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>أخبر طبيبك</strong> إذا كان لديك تاريخ مرضي من ارتفاع ضغط الدم</p><p dir="RTL">الأدوية الأخرى وويلبيترين أكس أل<!--[if supportFields]><span lang=AR-SA
style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-begin'></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>DOCVARIABLE</span><span dir=RTL></span><span dir=RTL></span><span
style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>VAULT_ND_532e5693-1374-475e-89e8-83ce2c612e12 \* MERGEFORMAT</span><span
dir=RTL></span><span dir=RTL></span><span style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;mso-bidi-font-weight:
bold'><span dir=RTL></span><span dir=RTL></span> <span lang=AR-SA><span
style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL"><strong>قم بإبلاغ الطبيب أو الصيدلاني إذا كنت تتناول أدوية أخرى، أو تناولت بعض الأدوية مؤخرًا أو عند بدء تناول أدوية جديدة،</strong> بما في ذلك الأدوية التي يمكن شراؤها دون وصفة طبية.</p><p>قد تكون هناك خطورة أكبر من المعتاد لحدوث نوبات إذا كنت تتناول <em>(انظر أيضًا &quot;النوبات (التشنجات)&quot; سابقًا في </em><br /><em>هذا القسم)</em>:<!--[if supportFields]><span
lang=AR-SA style='font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-begin'></span> </span><span dir=LTR style='font-size:13.0pt;font-family:
"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:bold'>DOCVARIABLE</span><span
dir=RTL></span><span dir=RTL></span><span style='font-size:13.0pt;font-family:
"Traditional Arabic",serif;mso-ansi-font-weight:normal;mso-bidi-font-weight:
bold'><span dir=RTL></span><span dir=RTL></span> </span><span dir=LTR
style='font-size:13.0pt;font-family:"Traditional Arabic",serif;font-weight:
normal;mso-bidi-font-weight:bold'>VAULT_ND_fdee9b8e-3293-4c3f-93de-d2ddaaa94b7b
\* MERGEFORMAT</span><span dir=RTL></span><span dir=RTL></span><span
style='font-size:13.0pt;font-family:"Traditional Arabic",serif;mso-ansi-font-weight:
normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span dir=RTL></span> <span
lang=AR-SA><span style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; <strong>منشطات</strong> أو أدوية أخرى للتحكم في وزنك <strong>أو</strong> شهيتك</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; أدوية<strong> مرض السكري</strong>.</p><p dir="RTL">&ccedil;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>إذا كنت تتناول أي من الأدوية المدرجة بهذه القائمة، تحدث إلى طبيبك فورًا،</strong> قبل تناول ويلبيترين أكس أل</p><p dir="RTL"><strong>قد تكون هناك خطورة أكبر من المعتاد لحدوث آثار جانبية أخرى أو مشكلات أخرى إذا كنت تتناول</strong> <em>(انظر أيضًا &quot;لا تتناول ويلبيترين</em> <em>أكس أل &quot; في القسم </em><em>2</em><em>)</em>:</p><p dir="RTL"><strong><em>&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong>أدوية أخرى لعلاج <strong>الاكتئاب </strong>أو <strong>مشاكل صحية نفسية أخرى</strong> )مثل ديسيبرامين أو مثبطات استرداد السيروتونين الانتقائية(SSRI) )</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; أدوية لعلاج <strong>مرض باركنسون</strong> (مثل ليفودوبا، أمانتادين أو أورفينادرين)</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; <strong>كاربامازيبين</strong> أو <strong>فينوباربيتال</strong> أو <strong>فينيتوين</strong> لعلاج <strong>الصرع</strong> أو لعلاج <strong>بعض المشكلات المتعلقة بالصحة النفسية</strong></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; بعض الأدوية المستخدمة لعلاج <strong>السرطان</strong> (مثل سيكلوفوسفاميد أو إيفوسفاميد أو تاموكسيفين)</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; <strong>تيكلوبيدين</strong> أو <strong>كلوبيدوجريل</strong>، المستخدم في الأساس لعلاج <strong>أمراض القلب</strong> أو <strong>السكتة الدماغية</strong></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; بعض <strong>محصرات بيتا</strong>، والمستخدمة في الأساس لعلاج ارتفاع ضغط الدم</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; بعض الأدوية لعلاج <strong>عدم انتظام ضربات القلب</strong></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; <strong>ريتونافير</strong> <strong>أو</strong> <strong>إيفافيرينز</strong>، وهي الأدوية المستخدمة في علاج الإصابة بفيروس نقص المناعة</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; <strong>لصقات معالجة النيكوتين بالإعاضة</strong><em> </em><em>(راجع &quot;ارتفاع ضغط الدم وويلبيترين</em> <em>أكس أل &quot; في القسم </em><em>2</em><em>)</em></p><p dir="RTL">&ccedil;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>ينبغي إخبار الطبيب أو الصيدلاني إذا كنت تتناول أي من هذه الأدوية</strong></p><p dir="RTL">الكحوليات وويلبيترين أكس أل <!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-begin'></span><span style='mso-spacerun:yes'> </span></span><span
dir=LTR style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
font-weight:normal;mso-bidi-font-weight:bold'>DOCVARIABLE</span><span dir=RTL></span><span
dir=RTL></span><span style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>VAULT_ND_d52c3ff3-0836-4bfd-a801-4d1d990c7891 \* MERGEFORMAT</span><span
dir=RTL></span><span dir=RTL></span><span style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;mso-bidi-font-weight:
bold'><span dir=RTL></span><span dir=RTL></span> <span lang=AR-SA><span
style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL">يجد بعض الناس أنفسهم أكثر حساسية للكحوليات عند تناول ويلبيترين أكس أل. قد يقترح طبيبك ألا تشرب الكحوليات أثناء تناول ويلبيترين أكس أل أو أن تحاول تقليل الكمية قدر الإمكان.</p><p dir="RTL">الفحوصات المخبرية<!--[if supportFields]><span lang=AR-SA style='mso-bidi-font-size:
13.0pt;font-family:"Traditional Arabic",serif;mso-bidi-font-weight:bold'><span
style='mso-element:field-begin'></span> </span><span dir=LTR style='mso-bidi-font-size:
13.0pt;font-family:"Traditional Arabic",serif;mso-bidi-font-weight:bold'>DOCVARIABLE</span><span
dir=RTL></span><span dir=RTL></span><span style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;mso-bidi-font-weight:bold'><span
dir=RTL></span><span dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:
13.0pt;font-family:"Traditional Arabic",serif;mso-bidi-font-weight:bold'>VAULT_ND_efac00ff-2a38-4b01-ba39-b8d6d1380854
\* MERGEFORMAT</span><span dir=RTL></span><span dir=RTL></span><span
style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-bidi-font-weight:bold'><span dir=RTL></span><span dir=RTL></span> <span
lang=AR-SA><span style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-bidi-font-weight:bold'><span style='mso-element:field-end'></span></span><![endif]--></p><p dir="RTL">قد يتعارض ويلبيترين أكس أل مع بعض الفحوصات المخبرية الخاصة بالكشف عن الأدوية الأخرى. إذا كنت في حاجة إلى فحص مخبري، أخبر الطبيب أو المستشفى بأنك تتناول ويلبيترين أكس أل.</p><p dir="RTL">الحمل والرضاعة الطبيعية<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-begin'></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>DOCVARIABLE</span><span dir=RTL></span><span dir=RTL></span><span
style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>VAULT_ND_1bfe28cc-834e-42e9-9c09-c4811cae0029 \* MERGEFORMAT</span><span
dir=RTL></span><span dir=RTL></span><span style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;mso-bidi-font-weight:
bold'><span dir=RTL></span><span dir=RTL></span> <span lang=AR-SA><span
style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL">إذا كنتِ<strong> حاملاً</strong> أو <strong>تظنين أنكِ حامل، </strong>أو كنتِ<strong> تنوين الحمل، لا تتناولي ويلبيترين أكس أل</strong> دون استشارة الطبيب. سوف يقدّر الطبيب<strong> </strong>الفائدة التي تعود عليكِ مقارنةً بالخطر الذي قد يهدد الجنين عند تناول ويلبيترين أكس أل أثناء الحمل. أفادت بعض الدراسات، وليس جميعها، بزيادة خطورة حدوث تشوهات خلقية، وخاصةً تشوهات القلب، في الأطفال الذين كانت أمهاتهم يتناولن ويلبيترين أكس أل. ومن غير المعروف ما إذا كان ذلك نتيجة لاستخدام ويلبيترين أكس أل.</p><p dir="RTL"><strong>لا يُنصح بالرضاعة الطبيعية</strong> أثناء العلاج بويلبيترين أكس أل. فقد تنتقل مكونات الدواء إلى لبن الأم، ومن ثَم تضر طفلك. تحدثي إلى طبيبِك في هذا الشأن.</p><p dir="RTL">القيادة واستخدام الآلات<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-begin'></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>DOCVARIABLE</span><span dir=RTL></span><span dir=RTL></span><span
style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>VAULT_ND_4acd66ff-7eed-4c0e-b296-23655dede581 \* MERGEFORMAT</span><span
dir=RTL></span><span dir=RTL></span><span style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;mso-bidi-font-weight:
bold'><span dir=RTL></span><span dir=RTL></span> <span lang=AR-SA><span
style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL">قد يؤثر ويلبيترين أكس أل على قدرتك على القيادة واستخدام الآلات.</p><p dir="RTL">&ccedil;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>تجنب القيادة أو استخدام الأجهزة</strong> ما لم تتأكد من عدم تأثرك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ينبغي تناول ويلبيترين أكس أل دائمًا وفقًا للجرعة التي حددها الطبيب. ويجب استشارة الطبيب أو الصيدلاني في حالة الشك بشأن طريقة استعماله على الوجه الصحيح.</p><p dir="RTL">الجرعة<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-begin'></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>DOCVARIABLE</span><span dir=RTL></span><span dir=RTL></span><span
style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>VAULT_ND_d30ca865-dcb5-40f0-a3b2-7bdc0ca73394 \* MERGEFORMAT</span><span
dir=RTL></span><span dir=RTL></span><span style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;mso-bidi-font-weight:
bold'><span dir=RTL></span><span dir=RTL></span> <span lang=AR-SA><span
style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL"><strong>الجرعة الأولية المعتادة </strong>هي<strong> </strong>قرص واحد 150 ملجم مرة واحدة يوميًا.</p><p dir="RTL"><strong>قد يزيد طبيبك الجرعة إلى </strong><strong>300</strong><strong> ملجم </strong>مرة واحدة يوميًا إذا لم يتحسن الاكتئاب بعد عدة أسابيع. إذا استمر عدم التحسن لعدة أسابيع أخرى، يمكن أن يتم زيادة الجرعة إلى 450 ملجم مرة واحدة يوميًا.</p><p dir="RTL">تناول جرعة ويلبيترين أكس أل في الصباح. يجب أن تكون الفترة بين الجرعات 24 ساعة على الأقل. <strong>لا تتناول ويلبيترين أكس أل أكثر من مرة واحدة في اليوم</strong>.</p><p dir="RTL">يغطي القرص غلاف يفرغ الدواء ببطء داخل جسمك. ربما تلاحظ شيئًا في البراز يبدو وكأنه قرص. هذا الأمر عادي. فهذا هو الغلاف الفارغ يخرج من جسمك.</p><p dir="RTL"><strong>قد يحتاج بعض الأشخاص إلى تناول جرعة أقل من ويلبيترين أكس أل</strong> للحد من خطر الإصابة بالآثار الجانبية:</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان عمرك يزيد عن 65 عامًا</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بأمراض الكبد أو الكلى</p><p dir="RTL"><strong>أبلغ الطبيب أو الصيدلاني إذا كانت أي من هذه الحالات تنطبق عليك.</strong></p><p dir="RTL">طريقة تناول الأقراص<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-begin'></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>DOCVARIABLE</span><span dir=RTL></span><span dir=RTL></span><span
style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>VAULT_ND_6b7593b9-e9c5-4341-a592-58e916a85900 \* MERGEFORMAT</span><span
dir=RTL></span><span dir=RTL></span><span style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;mso-bidi-font-weight:
bold'><span dir=RTL></span><span dir=RTL></span> <span lang=AR-SA><span
style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL"><strong>ابتلع أقراص ويلبيترين أكس أل كاملةً.</strong> <strong>لا تمضغها أو تسحقها أو تقسمها</strong> - فإذا قمت بذلك، سوف يتم إفراغ الدواء في جسمك بسرعة كبيرة جدًا. وهذا يجعلك أكثر عرضة لحدوث آثار جانبية، مثل النوبات.</p><p dir="RTL">مدة تناول ويلبيترين أكس أل<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-begin'></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>DOCVARIABLE</span><span dir=RTL></span><span dir=RTL></span><span
style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>VAULT_ND_204bbb3d-9e13-4541-8ffb-335643dd4bd9 \* MERGEFORMAT</span><span
dir=RTL></span><span dir=RTL></span><span style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;mso-bidi-font-weight:
bold'><span dir=RTL></span><span dir=RTL></span> <span lang=AR-SA><span
style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL"><strong>لا تتناول جرعات ويلبيترين أكس أل لمدة تزيد عن المدة التي أوصى بها الطبيب</strong>. يستغرق الأمر وقتًا حتى يظهر تأثير الدواء بالكامل، وقد يستغرق ذلك أسابيع أحيانًا.</p><p dir="RTL"><strong>تحدث مع طبيبك باستمرار</strong> لتحديد مدة استمرارك في تناول ويلبيترين أكس أل. عندما تشعر بالتحسن، قد ينصحك طبيبك أن تستمر في العلاج حتى لا يعود إليك الاكتئاب مرة أخرى.</p><p dir="RTL">في حالة نسيان تناول ويلبيترين أكس أل<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-begin'></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>DOCVARIABLE</span><span dir=RTL></span><span dir=RTL></span><span
style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>VAULT_ND_fa7db156-5d5e-44d9-afe3-8cefda085be1 \* MERGEFORMAT</span><span
dir=RTL></span><span dir=RTL></span><span style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;mso-bidi-font-weight:
bold'><span dir=RTL></span><span dir=RTL></span> <span lang=AR-SA><span
style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL"><strong>لا تتناول أقراصًا إضافية لتعويض الجرعة التي فاتتك.</strong> فقط تناول القرص التالي في الموعد المعتاد.</p><p dir="RTL">في حالة تناول جرعة زائدة من ويلبيترين أكس أل<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-begin'></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>DOCVARIABLE</span><span dir=RTL></span><span dir=RTL></span><span
style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>VAULT_ND_1121108a-488a-4548-9220-e1dabc2325bf \* MERGEFORMAT</span><span
dir=RTL></span><span dir=RTL></span><span style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;mso-bidi-font-weight:
bold'><span dir=RTL></span><span dir=RTL></span> <span lang=AR-SA><span
style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL">لا تتناول أقراصًا أكثر مما أوصى به الطبيب. فإذا تناولت أقراصًا زائدة عن الجرعة المحددة من ويلبيترين أكس أل، قد تصبح <strong>أكثر عرضة لحدوث آثار جانبية، مثل النوبات</strong>.</p><p dir="RTL">&ccedil;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>لا تتأخر. اتصل بالطبيب أو قسم الطوارئ بأقرب مستشفى</strong><strong> </strong><strong>على الفور</strong><strong>. </strong>ويُفضل أن تريهم<strong> </strong>عبوة ويلبيترين أكس أل<br />إن أمكن.</p><p dir="RTL">لا تتوقف عن تناول ويلبيترين أكس أل دون استشارة الطبيب المختص<!--[if supportFields]><span lang=AR-SA style='mso-bidi-font-size:
13.0pt;font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;
mso-bidi-font-weight:bold'><span style='mso-element:field-begin'></span> </span><span
dir=LTR style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
font-weight:normal;mso-bidi-font-weight:bold'>DOCVARIABLE</span><span dir=RTL></span><span
dir=RTL></span><span style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>VAULT_ND_d1580a79-9e68-4b70-963c-2b90ae8f4431 \* MERGEFORMAT</span><span
dir=RTL></span><span dir=RTL></span><span style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;mso-bidi-font-weight:
bold'><span dir=RTL></span><span dir=RTL></span> <span lang=AR-SA><span
style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL"><strong>لا تتوقف عن تناول ويلبيترين أكس أل ما لم ينصحك الطبيب بهذا. </strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما يحدث في جميع الأدوية، يمكن أن يتسبب ويلبيترين أكس أل في حدوث بعض الآثار الجانبية، لكن ليس بالضرورة أن يصاب جميع الأشخاص بهذه الأعراض.</p><p dir="RTL"><strong>النوبات (التشنجات)</strong></p><p dir="RTL">قد تحدث النوبات لشخص بين كل 1000 شخص تقريبًا يتناولون ويلبيترين أكس أل.</p><p dir="RTL">وتشمل <strong>أعراض النوبة</strong> حدوث تشنجات وعادةً فقدان الوعي. قد يعاني الشخص الذي تعرض للنوبة من تشوش بعد ذلك، وقد لا يتذكر ما حدث.</p><p dir="RTL">من الأرجح أن تحدث النوبات في حالة تناولك جرعات زائدة من ويلبيترين أكس أل أو إذا كنت تتناول بعض الأدوية الأخرى<br />أو إذا كنت معرضًا لخطورة أكبر من المعتاد لحدوث نوبات <em>(انظر &quot;توخي الحذر البالغ عند استعمال ويلبيترين أكس أل &quot; في القسم </em><em>2</em><em>).</em></p><p dir="RTL"><strong>&ccedil;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>في حالة حدوث نوبة، توقف عن تناول المزيد من أقراص ويلبيترين أكس أل. اتصل بطبيبك بعد زوال النوبة.</strong></p><p dir="RTL"><strong>الحساسية الشديدة</strong></p><p dir="RTL">نادرة جدًا (تصل إلى 1 في كل 10000) قد يصاب الأشخاص بحساسية شديدة لويلبيترين أكس أل. وتشمل علامات الحساسية:</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي، والذي قد يتقرّح ويشبه الأجزاء الناتئة الصغيرة (بقع سوداء متمركزة تحيط بها مساحة شاحبة، مع وجود حلقة داكنة حول الأطراف - <em>حمامى متعددة الأشكال</em>)</p><p dir="RTL"><em>&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; </em>طفح واسع الانتشار مصاحب بتقرّح وتقشير في الجلد، وخاصةً حول الفم والأنف والعيون والأعضاء التناسلية <em>(متلازمة ستيفنز جونسون)</em></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; أزيز صدري غير عادي، أو صعوبة في التنفس</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; انتفاخ الجفون أو الشفتين أو اللسان</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; آلام في العضلات أو المفاصل</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; الإغماء أو فقدان الوعي</p><p dir="RTL"><strong>&ccedil;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>في حالة ظهور أي من علامات الحساسية، توقف عن تناول المزيد من أقراص ويلبيترين أكس أل. اتصل بالطبيب<br />على الفور </strong></p><p dir="RTL"><strong>الطفح الجلدي الناتج عن مرض الذئبة أو تفاقم أعراضه</strong><strong>&nbsp;</strong></p><p dir="RTL">&ccedil;&nbsp;&nbsp; مرض الذئبة هو اضطراب الجهاز المناعي الذي يؤثر على الجلد والأعضاء الأخرى. نادراً جداً ما يصيب الأفراد (حتى 1 من بين 10.000) الطفح الجلدي الناتج عن مرض الذئبة أو تفاقم أعراضه خلال تناول ويلبيترين أكس أل. تتضمن الأعراض:&nbsp;&nbsp;</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; نوبات احتدام مرض الذئبة&nbsp;&nbsp;</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي أو آفات الجلد (خاصة المناطق المُعرضة للشمس)</p><p dir="RTL"><strong>&ccedil;&nbsp;&nbsp; </strong><strong>إذا أصابك الطفح الجلدي الناتج عن مرض الذئبة أو تفاقمت أعراض المرض اتصل بطبيبك فوراً، فقد يستلزم ذلك إيقاف العلاج</strong><strong>.&nbsp;</strong></p><p dir="RTL">الآثار الجانبية الشائعة جدًا<!--[if supportFields]><span lang=AR-SA style='mso-bidi-font-size:
13.0pt;font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;
mso-bidi-font-weight:bold'><span style='mso-element:field-begin'></span> </span><span
dir=LTR style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
font-weight:normal;mso-bidi-font-weight:bold'>DOCVARIABLE</span><span dir=RTL></span><span
dir=RTL></span><span style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>VAULT_ND_ce1af938-619e-493d-82e7-e8dc5a0e2e15 \* MERGEFORMAT</span><span
dir=RTL></span><span dir=RTL></span><span style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;mso-bidi-font-weight:
bold'><span dir=RTL></span><span dir=RTL></span> <span lang=AR-SA><span
style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL">يمكن أن تصيب تلك الآثار <strong>أكثر من شخص واحد بين كل </strong><strong>10</strong><strong> أشخاص</strong>:</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في النوم (أرق)</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; صداع، جفاف الفم</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالتوعك (غثيان)، إعياء (قيء)</p><p dir="RTL">الآثار الجانبية الشائعة<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-begin'></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>DOCVARIABLE</span><span dir=RTL></span><span dir=RTL></span><span
style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>VAULT_ND_90cf4106-9cd3-40b2-964f-11d5b3adaadc \* MERGEFORMAT</span><span
dir=RTL></span><span dir=RTL></span><span style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;mso-bidi-font-weight:
bold'><span dir=RTL></span><span dir=RTL></span> <span lang=AR-SA><span
style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL">قد تصيب <strong>شخصًا واحدًا بين كل </strong><strong>10</strong><strong> أشخاص</strong>:</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; حمى، دوار، تعرق، طفح جلدي (في بعض الأحيان بسبب الحساسية)، حكة</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالارتجاف (الارتعاش)، الشعور بالضعف، ألم في الصدر</p><p dir="RTL"><em>&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; </em>الشعور بالقلق أو الهياج، آلام في المعدة، الإمساك، تغييرات في مذاق الطعام، فقدان الشهية <em>(القهم)</em></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع في ضغط الدم (ارتفاع شديد في بعض الأحيان)، تبيغ الدم</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; ضجيج مستمر في الأذنين <em>(طنين)</em>، اضطرابات بصرية</p><p dir="RTL">الآثار الجانبية غير الشائعة<!--[if supportFields]><span lang=AR-SA style='mso-bidi-font-size:
13.0pt;font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;
mso-bidi-font-weight:bold'><span style='mso-element:field-begin'></span> </span><span
dir=LTR style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
font-weight:normal;mso-bidi-font-weight:bold'>DOCVARIABLE</span><span dir=RTL></span><span
dir=RTL></span><span style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>VAULT_ND_ede2779e-2599-4f36-8475-8cc9081cff22 \* MERGEFORMAT</span><span
dir=RTL></span><span dir=RTL></span><span style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;mso-bidi-font-weight:
bold'><span dir=RTL></span><span dir=RTL></span> <span lang=AR-SA><span
style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL">قد تصيب شخصًا <strong>واحدًا بين كل </strong><strong>100</strong><strong> شخص</strong>:</p><p dir="RTL"><em>&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; </em>الشعور بالاكتئاب <em>(انظر أيضًا &quot;توخي الحذر البالغ عند استعمال ويلبيترين أكس أل &quot; في القسم </em><em>2</em><em>)</em></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالارتباك</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في التركيز</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; سرعة ضربات القلب</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الوزن</p><p dir="RTL">الأعراض الجانبية النادرة<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-begin'></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>DOCVARIABLE</span><span dir=RTL></span><span dir=RTL></span><span
style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>VAULT_ND_4e73e214-050e-4a36-a3ed-4ecc7fad5839 \* MERGEFORMAT</span><span
dir=RTL></span><span dir=RTL></span><span style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;mso-bidi-font-weight:
bold'><span dir=RTL></span><span dir=RTL></span> <span lang=AR-SA><span
style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL">قد تصيب <strong>شخصًا واحدًا بين كل </strong><strong>1000</strong><strong> شخص</strong>:</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; نوبات <em>(انظر بداية هذا القسم)</em></p><p dir="RTL">الآثار الجانبية شديدة الندرة<!--[if supportFields]><span lang=AR-SA style='mso-bidi-font-size:
13.0pt;font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;
mso-bidi-font-weight:bold'><span style='mso-element:field-begin'></span> </span><span
dir=LTR style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
font-weight:normal;mso-bidi-font-weight:bold'>DOCVARIABLE</span><span dir=RTL></span><span
dir=RTL></span><span style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span dir=RTL></span><span
dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;font-weight:normal;mso-bidi-font-weight:
bold'>VAULT_ND_ec638033-f9d0-43a6-913e-fa402b06cb1e \* MERGEFORMAT</span><span
dir=RTL></span><span dir=RTL></span><span style='mso-bidi-font-size:13.0pt;
font-family:"Traditional Arabic",serif;mso-ansi-font-weight:normal;mso-bidi-font-weight:
bold'><span dir=RTL></span><span dir=RTL></span> <span lang=AR-SA><span
style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-ansi-font-weight:normal;mso-bidi-font-weight:bold'><span style='mso-element:
field-end'></span></span><![endif]--></p><p dir="RTL">قد تصيب <strong>شخصًا واحدًا بين كل </strong><strong>10000</strong><strong> شخص</strong>:</p><p dir="RTL"><em>&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; </em>&rlm;‫الحساسية الشديدة <em>(انظر بداية هذا القسم)</em></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي الناتج عن مرض الذئبة أو تفاقم أعراضه <em>(أنظر بداية هذا القسم)</em></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي المصحوب بالبثرات والتقرحات التي تحتوي على الصديد <em>(البُثار الطفحي الحاد المعمم)</em></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; تساقط الشعر أو ترقيقه بشكل غير عادي (الثعلبة).</p><p dir="RTL"><em>&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; </em>شعور عدواني، شعور عدائي، تعكر المزاج أو التململ، أحلام غريبة</p><p dir="RTL"><em>&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; </em>رؤية أو سماع أشياء غير موجود <em>(هلوسة)</em>، شعور غير واقعي أو غريب <em>(اختلال الأنية)،</em> استشعار أو الاعتقاد بأشياء غير صحيحة <em>(أوهام)</em>، ارتياب شديد<em> (جنون الارتياب)</em>، الأحساس بالخوف<em> (نوبات الهلع)</em></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الذاكرة</p><p dir="RTL"><em>&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; </em>نفضان، تشنجات في العضلات لا يمكن السيطرة عليها، حركات لا إرادية، مشكلات في المشي أو تنسيق الحركة <em>(</em>ترنح<em>)</em></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; التلعثم</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫وخز أو تنميل</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; إغماء، شعور بالإغماء عند الوقوف فجأة، بسبب هبوط ضغط الدم</p><p dir="RTL"><em>&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; </em>سرعة أو عدم انتظام ضربات القلب <em>(خفقان) </em></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; التبول (البول) أكثر أو أقل من المعتاد</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; سلس البول (التبول اللاإرادي، تسرب البول)</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; تغير لون البشرة أو بياض العين إلى اللون الأصفر <em>(يرقان)</em>، التهاب الكبد <em>(الالتهاب الكبدي)</em></p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; توسيع الأوعية الدموية (توسع الأوعية).</p><p dir="RTL">من بين الآثار الجانبية شديدة الندرة التي تظهرها فحوصات الدم:</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في مستوى أنزيمات الكبد</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في مستويات السكر في الدم</p><p dir="RTL">&Yuml;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض الصوديوم في الدم (نقص صوديوم الدم)</p><p dir="RTL">&ccedil;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>قم بإبلاغ الطبيب أو الصيدلاني</strong> في حالة تفاقم الآثار الجانبية أو إذا أصبحت مزعجة، أو إذا لاحظت آثارًا جانبية أخرى غير مبيَّنة في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-right:.25in; text-indent:-.25in"><!--[if !supportLists]--></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>يُحفظ الدواء بعيدًا عن متناول ومرأى الأطفال</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم ويلبيترين أكس أل بعد تاريخ انتهاء الصلاحية الموضح على العبوة. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من الشهر المذكور</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب تخزين ويلبيترين أكس أل عند درجة حرارة أقل من 25 درجة مئوية، في مكان جاف</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُحفظ في العبوة الأصلية للحماية من الرطوبة والضوء&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تحتوي الزجاجة على عبوة صغيرة مغلقة تحتوي على جيل الفحم والسيليكا، للإبقاء على الأقراص جافة. احتفظ بالعبوة داخل الزجاجة. لا تبتلعها</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يجوز التخلّص من الأدوية بإلقائها في الفضلات السائلة أو المخلفات المنزلية. وينبغي سؤال الصيدلاني عن الطريقة المناسبة للتخلّص من الأدوية التي لا يُحتاج إليها. فهذا من شأنه أن يساعد في الحفاظ على البيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">محتويات ويلبيترين أكس أل<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-bidi-font-weight:bold'><span style='mso-element:field-begin'></span> </span><span
dir=LTR style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-bidi-font-weight:bold'>DOCVARIABLE</span><span dir=RTL></span><span
dir=RTL></span><span style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-bidi-font-weight:bold'><span dir=RTL></span><span dir=RTL></span> </span><span
dir=LTR style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-bidi-font-weight:bold'>VAULT_ND_ad326479-6e1b-4b2b-a4c6-2522c59c4e50 \*
MERGEFORMAT</span><span dir=RTL></span><span dir=RTL></span><span
style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-bidi-font-weight:bold'><span dir=RTL></span><span dir=RTL></span> <span
lang=AR-SA><span style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-bidi-font-weight:bold'><span style='mso-element:field-end'></span></span><![endif]--></p><p dir="RTL">المادة الفعالة في هذا الدواء هي بوپروپيون هيدروكلورايد. تتوفر أقراص ويلبيترين أكس أل بتركيزات مختلفة.</p><p dir="RTL">يحتوي كل قرص من ويلبيترين أكس أل على:</p><p dir="RTL">150 أو 300&nbsp;ملجم بوپروپيون هيدروكلورايد</p><p dir="RTL"><strong>المكونات الأخرى هي: </strong></p><p dir="RTL"><strong>لب القرص </strong></p><p dir="RTL">&rlm;‫كحول عديد الفينيل</p><p dir="RTL">بينيت الجليسيريل</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غلاف القرص</strong></p><p dir="RTL">إيثيل سيللولوز 100</p><p dir="RTL">البولي إيثيلين جلايكول 1450</p><p dir="RTL">بوفيدون</p><p dir="RTL">بوليمر مبعثر حمض الميثاكريليك (أودراجيت L30 D-55)</p><p dir="RTL">ثاني أكسيد السيليكون</p><p dir="RTL">سترات الإيثيل الثلاثي</p><p dir="RTL">حبر أسود صالح للأكل (للطباعة)</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شكل ويلبيترين أكس أل ومحتويات العبوة<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-bidi-font-weight:bold'><span style='mso-element:field-begin'></span> </span><span
dir=LTR style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-bidi-font-weight:bold'>DOCVARIABLE</span><span dir=RTL></span><span
dir=RTL></span><span style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-bidi-font-weight:bold'><span dir=RTL></span><span dir=RTL></span> </span><span
dir=LTR style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-bidi-font-weight:bold'>VAULT_ND_e219089b-889a-4b4a-94ce-d7c4dd4bb93d \*
MERGEFORMAT</span><span dir=RTL></span><span dir=RTL></span><span
style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-bidi-font-weight:bold'><span dir=RTL></span><span dir=RTL></span> <span
lang=AR-SA><span style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:13.0pt;font-family:"Traditional Arabic",serif;
mso-bidi-font-weight:bold'><span style='mso-element:field-end'></span></span><![endif]--></p><p dir="RTL">زجاجات من البولي إيثيلين الأبيض غير الشفاف عالي الكثافة (HDPE) تحتوي مركب عبوة من الجيل من الفحم/السيليكا المجفف ومغلقة بغطاء مقاوم لعبث الأطفال يحتوي على</p><p dir="RTL">غطاء مقاوم للحرارة.</p><p dir="RTL">150 ملجم: 30 قرصًا</p><p dir="RTL">300 ملجم: 30 قرصًا</p><p dir="RTL">لا تتوفر كل العبوات في كل الدول.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>ويلبيترين أكس إل</em> هي علامة تجارية مملوكة أو مرخصة لمجموعة شركات جلاكسو سميث كلاين.</p><p dir="RTL">&copy; ٢٠٢٤ &nbsp;مجموعة شركات جلاكسو سميث كلاين. جميع الحقوق محفوظة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الشركة المُصنعة:</strong></p><p dir="RTL">شركات باوش هيلث، إنك&nbsp;</p><p dir="RTL">قسم التصنيع، 100 لايف ساينسز باركواي، شتاينباخ، MB، كندا &nbsp;R5G 1Z7</p><p dir="RTL"><strong>تعبئة:</strong></p><p dir="RTL">جلاكسو ويلكام أس.أيه*، أراندا، إسبانيا</p><p dir="RTL"><strong>صاحبة رخصة التسويق:</strong></p><p dir="RTL">جلاكسو العربية السعودية المحدودة، جدة، المملكة العربية السعودية</p><p dir="RTL">* عضو مجموعة شركات جلاكسو سميث كلاين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للاستفسار عن أية معلومات عن هذا المستحضر الدوائي، يرجى الاتصال بالأرقام التالية:</strong></p><p dir="RTL"><strong>جلاكسو سميث كلاين &ndash; المكتب الرئيسي، جدة.</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هاتف: 6536666 (12) 966 +</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جوال: 9882-904-56 &nbsp;966 +</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني : <u>&nbsp;</u>gcc.medinfo@gsk.com</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني : <u>&nbsp;</u>https://gskpro.com/en-sa/</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ص.ب 55850، جدة 21544، المملكة العربية السعودية.</p><p>&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><!--[if gte vml 1]><v:roundrect id="AutoShape_x0020_5" o:spid="_x0000_s1026"
 style='position:absolute;left:0;text-align:left;margin-left:-8pt;margin-top:14.15pt;
 width:481.9pt;height:233.5pt;z-index:251659776;visibility:visible;
 mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
 mso-width-relative:page;mso-height-relative:page;v-text-anchor:top' arcsize="10923f"
 o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" strokeweight="2.5pt">
 <v:shadow color="#868686"/>
 <v:textbox inset=",0,,0">
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal dir=RTL style='margin-bottom:0in;text-align:right;
    direction:rtl;unicode-bidi:embed'><b><span lang=AR-SA style='font-size:
    14.0pt;font-family:"Traditional Arabic",serif'>للإبلاغ عن أية آثار جانبية</span></b><b><span
    lang=AR-SA style='mso-bidi-font-size:12.0pt;font-family:"Traditional Arabic",serif'>:</span></b><b><span
    dir=LTR style='mso-bidi-font-size:12.0pt;font-family:"Traditional Arabic",serif'><o:p></o:p></span></b></p>
    <p class=MsoNormal dir=RTL style='margin-bottom:0in;text-align:right;
    direction:rtl;unicode-bidi:embed'><b><i><span lang=AR-SA style='font-size:
    13.0pt;font-family:"Traditional Arabic",serif'>المملكة العربية السعودية</span></i></b><b><i><span
    dir=LTR style='font-size:13.0pt;font-family:"Traditional Arabic",serif'><o:p></o:p></span></i></b></p>
    <p class=MsoNormal dir=RTL style='margin-bottom:0in;text-align:right;
    line-height:115%;direction:rtl;unicode-bidi:embed'><span dir=RTL></span><span
    dir=RTL></span><b><span lang=AR-SA style='font-size:11.0pt;line-height:
    115%;font-family:"Traditional Arabic",serif'><span dir=RTL></span><span
    dir=RTL></span>- </span></b><b><span lang=AR-SA style='font-size:11.0pt;
    line-height:115%;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:
    major-bidi;mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:
    major-bidi;mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi'>المركز
    الوطني للتيقظ والسلامة الدوائية (</span></b><b><span dir=LTR
    style='font-size:11.0pt;line-height:115%;mso-ascii-font-family:"Times New Roman";
    mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
    mso-bidi-theme-font:major-bidi'>NPC</span></b><span dir=RTL></span><span
    dir=RTL></span><b><span lang=AR-SA style='font-size:11.0pt;line-height:
    115%;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
    mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi'><span
    dir=RTL></span><span dir=RTL></span>)</span></b><b><span dir=LTR
    style='font-size:11.0pt;line-height:115%;mso-ascii-font-family:"Times New Roman";
    mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
    mso-bidi-theme-font:major-bidi'><o:p></o:p></span></b></p>
    <p class=MsoListParagraph dir=RTL style='margin-top:0in;margin-right:.5in;
    margin-bottom:0in;margin-left:0in;text-align:right;text-indent:-.25in;
    line-height:115%;mso-list:l1 level1 lfo1;direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
    style='font-size:11.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:
    Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-size:11.0pt;line-height:115%;
    mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
    mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi'>الاتصال
    بالرقم الموحد: 19999<span style='mso-spacerun:yes'>  </span><o:p></o:p></span></p>
    <p class=MsoListParagraph dir=RTL style='margin-top:0in;margin-right:.5in;
    margin-bottom:0in;margin-left:0in;text-align:right;text-indent:-.25in;
    line-height:115%;mso-list:l1 level1 lfo1;direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
    style='font-size:11.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:
    Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-size:11.0pt;line-height:115%;
    mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
    mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi'>البريد
    الإلكتروني: </span><a href="mailto:npc.drug@sfda.gov.sa"><span dir=LTR
    style='font-size:11.0pt;line-height:115%;mso-ascii-font-family:"Times New Roman";
    mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
    mso-bidi-theme-font:major-bidi'>npc.drug@sfda.gov.sa</span></a><span
    dir=LTR style='font-size:11.0pt;line-height:115%;mso-ascii-font-family:
    "Times New Roman";mso-ascii-theme-font:major-bidi;mso-hansi-font-family:
    "Times New Roman";mso-hansi-theme-font:major-bidi;mso-bidi-font-family:
    "Times New Roman";mso-bidi-theme-font:major-bidi'> <o:p></o:p></span></p>
    <p class=MsoListParagraph dir=RTL style='margin-top:0in;margin-right:.5in;
    margin-bottom:0in;margin-left:0in;text-align:right;text-indent:-.25in;
    line-height:115%;mso-list:l1 level1 lfo1;direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
    lang=EN-US style='font-size:11.0pt;line-height:115%;font-family:Symbol;
    mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:
    EN-US'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
    style='font-size:11.0pt;line-height:115%;mso-ascii-font-family:"Times New Roman";
    mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
    mso-bidi-theme-font:major-bidi'>الموقع الإلكتروني:<span class=MsoHyperlink>
    </span></span><a href="https://ade.sfda.gov.sa/"><span lang=EN-US dir=LTR
    style='font-size:11.0pt;line-height:115%;mso-ascii-font-family:"Times New Roman";
    mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
    mso-bidi-theme-font:major-bidi;mso-ansi-language:EN-US'>https://ade.sfda.gov.sa</span></a><u><span
    lang=EN-US dir=LTR style='font-size:11.0pt;line-height:115%;mso-ascii-font-family:
    "Times New Roman";mso-ascii-theme-font:major-bidi;mso-hansi-font-family:
    "Times New Roman";mso-hansi-theme-font:major-bidi;mso-bidi-font-family:
    "Times New Roman";mso-bidi-theme-font:major-bidi;color:blue;mso-ansi-language:
    EN-US'><o:p></o:p></span></u></p>
    <p class=MsoNormal dir=RTL style='margin-top:0in;margin-right:.25in;
    margin-bottom:0in;margin-left:0in;text-align:right;direction:rtl;
    unicode-bidi:embed'><span dir=LTR style='font-size:11.0pt;mso-ascii-font-family:
    "Times New Roman";mso-ascii-theme-font:major-bidi;mso-hansi-font-family:
    "Times New Roman";mso-hansi-theme-font:major-bidi;mso-bidi-font-family:
    "Times New Roman";mso-bidi-theme-font:major-bidi'><o:p>&nbsp;</o:p></span></p>
    <p class=MsoNormal dir=RTL style='margin-bottom:0in;text-align:right;
    line-height:115%;direction:rtl;unicode-bidi:embed'><span dir=RTL></span><span
    dir=RTL></span><b><span lang=AR-SA style='font-size:11.0pt;line-height:
    115%;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
    mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi'><span
    dir=RTL></span><span dir=RTL></span>- جلاكسو سميث كلاين – المكتب الرئيسي،
    جدة.</span></b><b><span dir=LTR style='font-size:11.0pt;line-height:115%;
    mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
    mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi'><o:p></o:p></span></b></p>
    <p class=MsoListParagraphCxSpFirst dir=RTL style='margin-top:0in;
    margin-right:.5in;margin-bottom:0in;margin-left:0in;mso-add-space:auto;
    text-align:right;text-indent:-.25in;line-height:115%;mso-list:l1 level1 lfo1;
    tab-stops:right 13.5pt;direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
    style='font-size:11.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:
    Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-size:11.0pt;line-height:115%;
    mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
    mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi'>هاتف:
    6536666 (12) 966 +<o:p></o:p></span></p>
    <p class=MsoListParagraphCxSpMiddle dir=RTL style='margin-top:0in;
    margin-right:.5in;margin-bottom:0in;margin-left:0in;mso-add-space:auto;
    text-align:right;text-indent:-.25in;line-height:115%;mso-list:l1 level1 lfo1;
    tab-stops:right 13.5pt;direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
    style='font-size:11.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:
    Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-size:11.0pt;line-height:115%;
    mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
    mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi'>جوال:
    9882-904-56 -966 +<o:p></o:p></span></p>
    <p class=MsoListParagraphCxSpMiddle dir=RTL style='margin-top:0in;
    margin-right:.5in;margin-bottom:0in;margin-left:0in;mso-add-space:auto;
    text-align:right;text-indent:-.25in;line-height:115%;mso-list:l1 level1 lfo1;
    tab-stops:right 13.5pt;direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
    style='font-size:11.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:
    Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-size:11.0pt;line-height:115%;
    mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
    mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi'>البريد
    الإلكتروني : </span><u><span dir=LTR style='font-size:11.0pt;line-height:
    115%;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
    mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
    color:blue'>s</span></u><span dir=LTR><a href="mailto:audi.safety@gsk.com"><span
    style='font-size:11.0pt;line-height:115%;mso-ascii-font-family:"Times New Roman";
    mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
    mso-bidi-theme-font:major-bidi'>audi.safety@gsk.com</span></a></span><span
    lang=AR-SA style='font-size:11.0pt;line-height:115%;mso-ascii-font-family:
    "Times New Roman";mso-ascii-theme-font:major-bidi;mso-hansi-font-family:
    "Times New Roman";mso-hansi-theme-font:major-bidi;mso-bidi-font-family:
    "Times New Roman";mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
    <p class=MsoListParagraphCxSpMiddle dir=RTL style='margin-top:0in;
    margin-right:.5in;margin-bottom:0in;margin-left:0in;mso-add-space:auto;
    text-align:right;text-indent:-.25in;line-height:115%;mso-list:l1 level1 lfo1;
    tab-stops:right 13.5pt;direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
    style='font-size:11.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:
    Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-size:11.0pt;line-height:115%;
    mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
    mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi'>الموقع
    الإلكتروني:</span><a href="https://gskpro.com/en-sa/"><span dir=LTR
    style='font-size:11.0pt;line-height:115%;mso-ascii-font-family:"Times New Roman";
    mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
    mso-bidi-theme-font:major-bidi'>https://gskpro.com/en-sa</span><span
    dir=RTL></span><span dir=RTL></span><span lang=AR-SA style='font-size:11.0pt;
    line-height:115%;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:
    major-bidi;mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:
    major-bidi;mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi'><span
    dir=RTL></span><span dir=RTL></span>/</span></a><span lang=AR-SA
    style='font-size:11.0pt;line-height:115%;mso-ascii-font-family:"Times New Roman";
    mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
    mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
    <p class=MsoListParagraphCxSpLast dir=RTL style='margin-top:0in;margin-right:
    .5in;margin-bottom:0in;margin-left:0in;mso-add-space:auto;text-align:right;
    text-indent:-.25in;line-height:115%;mso-list:l1 level1 lfo1;tab-stops:right 13.5pt;
    direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
    style='font-size:11.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:
    Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
    dir=RTL></span><span lang=AR-SA style='font-size:11.0pt;line-height:115%;
    mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
    mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
    mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi'>ص.ب
    55850، جدة 21544، المملكة العربية السعودية.</span><span dir=LTR
    style='font-size:11.0pt;line-height:115%;mso-ascii-font-family:"Times New Roman";
    mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
    mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
    mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='margin-bottom:0in;text-align:right;
    tab-stops:right 13.5pt;direction:rtl;unicode-bidi:embed'><span dir=LTR
    style='font-size:11.0pt;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:
    major-bidi;mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:
    major-bidi;mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi'><o:p>&nbsp;</o:p></span></p>
    <p class=MsoNormal dir=RTL style='margin-bottom:0in;text-align:right;
    tab-stops:right 13.5pt;direction:rtl;unicode-bidi:embed'><span lang=EN-US
    dir=LTR style='mso-bidi-font-size:12.0pt;font-family:"Traditional Arabic",serif;
    mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap anchorx="margin"/>
</v:roundrect><![endif]--><img width="649" height="318" alt="Rectangle: Rounded Corners: للإبلاغ عن أية آثار جانبية:
المملكة العربية السعودية
- المركز الوطني للتيقظ والسلامة الدوائية (NPC)
•	الاتصال بالرقم الموحد: 19999  
•	البريد الإلكتروني: npc.drug@sfda.gov.sa 
•	الموقع الإلكتروني: https://ade.sfda.gov.sa

- جلاكسو سميث كلاين – المكتب الرئيسي، جدة.
•	هاتف: 6536666 (12) 966 +
•	جوال: 9882-904-56 -966 +
•	البريد الإلكتروني : saudi.safety@gsk.com
•	الموقع الإلكتروني:https://gskpro.com/en-sa/
•	ص.ب 55850، جدة 21544، المملكة العربية السعودية.


" src="file:///C:/Users/aa630244/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png" />&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            رقم إصدار النص:GDS35
تاريخ الإصدار:  7 يونيو 2024

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                WELLBUTRIN XL
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                WELLBUTRIN XL is available as:
•	tablets containing 150 mg of bupropion hydrochloride
•	tablets containing 300 mg of bupropion hydrochloride 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Extended release film-coated tablet.
150 mg tablet.: Creamy white to pale yellow round tablet imprinted with “GS5FV” in black ink on one side and the other side plain.
300 mg tablet: Creamy white to pale yellow round tablet imprinted with“GS5YZ” in black ink on one side and the other side plain.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>WELLBUTRIN</em> <em>XL </em>is indicated for the treatment of major depressive episodes.&nbsp; Following satisfactory response, continuation with <em>WELLBUTRIN XL </em>therapy is effective in preventing relapse.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>WELLBUTRIN XL </em>tablets should be swallowed whole. The tablets should not be cut<strong><em>, </em></strong>crushed or chewed as this may lead to an increased risk of adverse effects including seizures.<!--[if supportFields]><span style='mso-ascii-font-family:
"Times New Roman";mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:major-bidi;color:black'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_30b9c574-937e-4b70-b6bb-7fd0ef3ce48e \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
color:black'><span style='mso-element:field-end'></span></span><![endif]--></p><p><em>WELLBUTRIN XL</em> tablets can be taken with or without food<strong><em>.</em></strong><!--[if supportFields]><b style='mso-bidi-font-weight:
normal'><i style='mso-bidi-font-style:normal'><span style='mso-ascii-font-family:
"Times New Roman";mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:major-bidi;color:black'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_a0d78ac6-48f6-42e3-bf8a-da05df1a6106 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span></i></b><![endif]--><strong><em>&nbsp;</em></strong><!--[if supportFields]><b
style='mso-bidi-font-weight:normal'><i style='mso-bidi-font-style:normal'><span
style='mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
color:black'><span style='mso-element:field-end'></span></span></i></b><![endif]--></p><p>Use in Adults</p><p>The maximum single dose of <em>WELLBUTRIN XL </em>is 300<strong><em>&nbsp;</em></strong>mg.<!--[if supportFields]><span
style='mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
color:black'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_efd7d471-c960-46ed-9792-053f7d9703d4 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
color:black'><span style='mso-element:field-end'></span></span><![endif]--></p><p>There should be an interval of at least 24 hours between successive doses.<!--[if supportFields]><span style='mso-bidi-font-size:
12.0pt;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
color:black'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_7e45bd15-51d9-4d99-8927-bf59b7bac80a \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='mso-bidi-font-size:12.0pt;mso-ascii-font-family:"Times New Roman";
mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:major-bidi;color:black'><span style='mso-element:field-end'></span></span><![endif]--></p><p>Insomnia is a very common adverse event which is often transient. Insomnia may be reduced by avoiding dosing at bedtime (provided there is at least 24 hours between doses) or if clinically indicated, dose reduction.<!--[if supportFields]><span style='mso-ascii-font-family:
"Times New Roman";mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:major-bidi;color:black'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_236d0a86-285b-4d11-9428-6a84b46e8d55 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
color:black'><span style='mso-element:field-end'></span></span><![endif]--></p><p><strong>Initial Treatment</strong><!--[if supportFields]><b
style='mso-bidi-font-weight:normal'><span style='mso-ascii-font-family:"Times New Roman";
mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:major-bidi;color:black'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_2247880f-7ee0-40bb-baad-d47e99b51d11 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span></b><![endif]--><strong>&nbsp;</strong><!--[if supportFields]><b
style='mso-bidi-font-weight:normal'><span style='mso-ascii-font-family:"Times New Roman";
mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:major-bidi;color:black'><span style='mso-element:field-end'></span></span></b><![endif]--></p><p>The initial dose of <em>WELLBUTRIN XL<strong> </strong></em>tablets is 150&nbsp;mg taken as a single daily dose in the morning. Patients who are not responding adequately to a dose of 150&nbsp;mg/day may benefit from an increase to the usual adult target dose of 300&nbsp;mg/day, given once daily</p><p>The onset of action with bupropion has been noted as early as 14 days after starting therapy. As with all antidepressants the full antidepressant effect of <em>WELLBUTRIN XL</em> may not be evident until after several weeks of treatment.</p><p><strong>Switching Patients from WELLBUTRIN SR tablets</strong></p><p>When switching patients from <em>WELLBUTRIN SR</em> <strong>(</strong>sustained release)<strong><em> </em></strong>tablets to <em>WELLBUTRIN XL</em> tablets, give the same total daily dose when possible. Patients who are currently being treated with WELLBUTRIN SR tablets at 300&nbsp;mg/day (for example, 150&nbsp;mg twice daily) may be switched to <em>WELLBUTRIN XL</em> 300&nbsp;mg once daily.</p><p><strong>Maintenance therapy</strong></p><p>It is generally agreed that acute episodes of depression require 6 months or longer of antidepressant drug treatment. Bupropion (300&nbsp;mg/day) was shown to be efficacious during long-term (up to 1 year) treatment.</p><p><strong>Use in Children and Adolescents</strong></p><p><em>WELLBUTRIN XL</em> is not indicated for use in children or adolescents aged less than 18<strong><em> </em></strong>years (see Special warnings and precautions for use). The safety and efficacy of <em>WELLBUTRIN XL </em>tablets in patients under 18 years of age have not been established.</p><p><strong>Use in elderly</strong></p><p>Greater sensitivity of some elderly individuals to bupropion cannot be ruled out, hence a reduced frequency and/or dose may be required (see Special warnings and precautions for use).</p><p><strong>Use in patients with hepatic &nbsp;impairment</strong></p><p><em>WELLBUTRIN XL </em>should be used with caution in patients with liver impairment.</p><p>Because of increased variability in the pharmacokinetics in patients with mild to moderate hepatic cirrhosis, a reduced frequency of dosing should be considered (see Special warnings and precautions for use).</p><p><em>WELLBUTRIN XL </em>should be used with extreme caution in patients with severe hepatic cirrhosis. The dose should not exceed 150&nbsp;mg on alternate days in these patients (see Special warnings and precautions for use).</p><p><strong>Use in patients with renal impairment</strong></p><p>Treatment of patients with renal impairment should be initiated at reduced frequency and/or dose, as bupropion and its active metabolites may accumulate in such patients to a greater extent than usual (see Special warnings and precautions for use).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                WELLBUTRIN XL is contraindicated in patients with hypersensitivity to bupropion or any of the other components of the preparation.
WELLBUTRIN XL is contraindicated in patients with a seizure disorder.
WELLBUTRIN XL is contraindicated in patients undergoing abrupt discontinuation of alcohol or sedatives.
WELLBUTRIN XL tablets contain bupropion and should not be administered to patients currently being treated with any other preparation containing bupropion as the incidence of seizures is dose dependent.
WELLBUTRIN XL is contraindicated in patients with a current or previous diagnosis of bulimia or anorexia nervosa as a higher incidence of seizures was seen in this patient population when an immediate release form of bupropion was administered.
Concomitant use of WELLBUTRIN XL and monoamine oxidase inhibitors (MAOIs) is contraindicated. At least 14 days should elapse between discontinuation of irreversible MAOIs and initiation of treatment with WELLBUTRIN XL tablets

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Seizures</p><p>The recommended dose of <em>WELLBUTRIN XL</em> should not be exceeded, since bupropion is associated with a dose-related risk of seizure. The overall incidence of seizure with <em>WELLBUTRIN XL</em> in clinical trials at doses up to 450<strong><em>&nbsp;</em></strong>SSSSmg/day was approximately 0.1%.</p><p>The risk of seizures occurring with the use of bupropion appears to be strongly associated with the presence of predisposing risk factors. Therefore <em>WELLBUTRIN XL</em> should be administered with extreme caution to patients with one or more conditions predisposing to a lowered seizure threshold. These include:</p><p>-&nbsp;&nbsp;&nbsp; history of head trauma<br />-&nbsp;&nbsp;&nbsp; central nervous system (CNS) tumour<br />-&nbsp;&nbsp;&nbsp; history of seizures<br />-&nbsp;&nbsp;&nbsp; concomitant administration of other medications known to lower the seizure<br />&nbsp;&nbsp;&nbsp;&nbsp; threshold.</p><p>In addition, caution should be used in those clinical circumstances associated with an increased risk of seizures. These include excessive use of alcohol or sedatives see<strong><em> </em></strong>Contraindications), diabetes treated with hypoglycaemics or insulin and use of stimulants or anorectic products.</p><p><em>WELLBUTRIN XL</em> should be discontinued and not recommenced in patients who experience a seizure while on treatment.</p><p>Hypersensitivity reactions</p><p><em>WELLBUTRIN XL</em> should be discontinued promptly if patients experience hypersensitivity reactions during treatment (see Adverse Reactions). Clinicians should be aware that symptoms may persist beyond the discontinuation of bupropion, and clinical management should be provided accordingly.</p><p>Brugada-Type ECG&nbsp;<br />Bupropion may unmask Brugada syndrome, a rare hereditary disease of the cardiac sodium channel with characteristic ECG changes (ST&nbsp;segment elevation and T wave abnormalities in the right precordial&nbsp;leads), which may lead to cardiac arrest and/or sudden death. Caution&nbsp;is advised in patients with Brugada syndrome or risk factors such as a family history of cardiac arrest or sudden death.</p><p>Hepatic impairment</p><p>Bupropion is extensively metabolised in the liver to active metabolites, which are further metabolised. No statistically significant differences in the pharmacokinetics of bupropion were observed in patients with mild to moderate hepatic cirrhosis compared with healthy volunteers, but bupropion plasma levels showed a higher variability between individual patients. Therefore <em>WELLBUTRIN XL</em> should be used with caution in patients with hepatic impairment and reduced frequency of dosing should be considered in patients with mild to moderate hepatic cirrhosis (see Dosage and Administration and Pharmacokinetics).</p><p><em>WELLBUTRIN XL</em> should be used with extreme caution in patients with severe hepatic cirrhosis. In these patients a reduced frequency of dosing is required, as peak bupropion levels are substantially increased, and accumulation is likely to occur in such patients to a greater extent than usual (see Dosage and Administration and Pharmacokinetics).</p><p>All patients with hepatic impairment should be closely monitored for possible adverse effects (e.g., insomnia, dry mouth, seizures) that could indicate high drug or metabolite levels.</p><p>Renal impairment</p><p>Bupropion is extensively metabolised in the liver to active metabolites which are further metabolised and excreted by the kidneys. Therefore treatment of patients with renal impairment should be initiated at reduced frequency and/or dose as bupropion and its metabolites may accumulate in such patients to a greater extent than usual (see Pharmacokinetics). The patient should be closely monitored for possible adverse effects (e.g., insomnia, dry mouth, seizures) that could indicate high drug or metabolite levels.&nbsp;</p><p>Elderly patients</p><p>Clinical experience with bupropion has not identified any differences in tolerability between elderly and other adult patients. However, greater sensitivity of some elderly individuals to bupropion cannot be ruled out; hence a reduced frequency and/or dose may be required (see Pharmacokinetics).</p><p>Children and adolescents &lt;18 years</p><p>Treatment with antidepressants is associated with an increased risk of suicidal thinking and behaviour in children and adolescents with major depressive disorder and other psychiatric disorders.</p><p>Clinical worsening and suicide risk in adults with psychiatric disorders</p><p>Patients with depression may experience worsening of their depressive symptoms and/or the emergence of suicidal ideation and behaviours (suicidality) whether or not they are taking antidepressant medications. This risk persists until significant remission occurs. As improvement may not occur during the first few weeks or more of treatment, patients should be closely monitored for clinical worsening (including development of new symptoms) and suicidality, especially at the beginning of a course of treatment, or at the time of dose changes, either increases or decreases. It is general clinical experience with all antidepressant therapies that the risk of suicide may increase in the early stages of recovery.&nbsp;</p><p>Patients with a history of suicidal behaviour or thoughts, young adults, and those patients exhibiting a significant degree of suicidal ideation prior to commencement of treatment, are at a greater risk of suicidal thoughts or suicide attempts, and should receive careful monitoring during treatment.</p><p>In addition, a meta-analysis of placebo controlled clinical trials of antidepressant drugs in adults with major depressive disorder and other psychiatric disorders showed an increased risk of suicidal thinking and behaviour associated with antidepressant use compared to placebo in patients less than 25 years old.</p><p>Patients, (and caregivers of patients) should be alerted about the need to monitor for any worsening of their condition (including development of new symptoms) and/or the emergence of suicidal ideation/behaviour or thoughts of harming themselves and to seek medical advice immediately if these symptoms present. It should be recognised that the onset of some neuropsychiatric symptoms could be related either to the underlying disease state or the drug therapy (see Neuropsychiatric symptoms including mania and bipolar disorder below; Adverse Reactions).</p><p>Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients who experience clinical worsening (including development of new symptoms) and/or the emergence of suicidal ideation/behaviour, especially if these symptoms are severe, abrupt in onset, or were not part of the patient&rsquo;s presenting symptoms.</p><p>Neuropsychiatric symptoms including mania and bipolar disorder</p><p>Neuropsychiatric symptoms have been reported (<em>see Adverse Reactions</em>). In particular, psychotic and manic symptomatology has been observed, mainly in patients with a history of psychiatric illness. Additionally, a major depressive episode may be the initial presentation of bipolar disorder. It is generally believed (though not established in controlled trials) that treating such an episode with an antidepressant alone can increase the likelihood of precipitation of a mixed/manic episode in patients at risk for bipolar disorder. Limited clinical data on use of bupropion in combination with mood stabilisers in patients with a history of bipolar disorder suggests a low rate of switch to mania. Prior to initiating treatment with an antidepressant, patients should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression.</p><p>Cardiovascular disease</p><p>There is limited clinical experience of the use of bupropion to treat depression in patients with cardiovascular disease. Care should be exercised if <em>WELLBUTRIN XL</em> is used in these patients. However, bupropion was generally well tolerated in studies for smoking cessation in patients with ischaemic cardiovascular disease (see Pharmacological Properties and Clinical Studies).</p><p>Blood pressure</p><p>In a study in non-depressed subjects (including both smokers and non-smokers) with untreated Stage I hypertension, bupropion did not produce a statistically significant effect on blood pressure. However, spontaneous reports of increased blood pressure (sometimes severe) have been received (see Adverse Reactions), and concomitant use of bupropion and a Nicotine Transdermal System may result in elevations of blood pressure (see Interaction with other medicinal products and other forms of interaction).</p><p>Inappropriate routes of administration<!--[if supportFields]><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman",serif;
mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi;mso-bidi-font-weight:bold;font-style:normal;mso-bidi-font-style:
italic'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_57292849-017a-4e3b-8073-8b38739dbc9e \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman",serif;
mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi;mso-bidi-font-weight:bold;font-style:normal;mso-bidi-font-style:
italic'><span style='mso-element:field-end'></span></span><![endif]--></p><p>WELLBUTRIN XL is intended for oral use only. The inhalation of crushed tablets or injection of dissolved bupropion has been reported, and may lead to a rapid release, faster absorption and a potential overdose. Seizures and/or cases of death have been reported when bupropion has been administered intra-nasally or by parenteral injection.</p><p><strong>Serotonin syndrome</strong></p><p>Serotonin syndrome has been reported when bupropion is co-administered with drugs known to be associated with serotonin syndrome, including selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs). If concomitant treatment with other serotonergic agents is clinically warranted, careful observation of the patient is advised, particularly during treatment initiation and dose increases (see Interaction with other medicinal products and other forms of interaction).</p><p>Serotonin syndrome has also been reported with bupropion-only overdose (See Overdose).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Bupropion is metabolised to its major active metabolite hydroxybupropion primarily by the cytochrome P450 IIB6 (CYP2B6) (see Pharmacokinetics). Care should therefore be exercised when <em>WELLBUTRIN XL</em> is co-administered with drugs known to affect the CYP2B6 isoenzyme (e.g. orphenadrine, cyclophosphamide, ifosfamide, ticlopidine, clopidogrel).</p><p>Although bupropion is not metabolised by the CYP2D6 isoenzyme, <em>in vitro</em> human P450 studies have shown that bupropion and hydroxybupropion are inhibitors of the CYP2D6 pathway. In a human pharmacokinetic study, administration of bupropion increased plasma levels of desipramine. This effect was present for at least 7 days after the last dose of bupropion. Concomitant therapy with drugs predominantly metabolised by this isoenzyme (such as certain beta-blockers, antiarrhythmics, selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, antipsychotics) should be initiated at the lower end of the dose range of the concomitant medication. If <em>WELLBUTRIN XL</em> is added to the treatment regimen of a patient already receiving a medication metabolised by CYP2D6, the need to decrease the dose of the original medication should be considered, particularly for those concomitant medications with a narrow therapeutic index (see Pharmacokinetics).</p><p>Drugs which require metabolic activation by CYP2D6 in order to be effective (e.g. tamoxifen), may have reduced efficacy when administered concomitantly with inhibitors of CYP2D6 such as bupropion.</p><p>Although citalopram (a SSRI) is not primarily metabolised by CYP2D6, in one study, bupropion increased the CRR<sub>max</sub>RR and AUC of citalopram by 30% and 40%, respectively.</p><p>Since bupropion is extensively metabolised, the co-administration of drugs known to induce metabolism (e.g. carbamazepine, phenobarbitone, phenytoin, ritonavir, efavirenz) or inhibit metabolism may affect its clinical activity.</p><p>In a series of studies in healthy volunteers, ritonavir (100&nbsp;mg twice daily or 600&nbsp;mg twice daily) or ritonavir 100&nbsp;mg plus lopinavir 400&nbsp;mg twice daily reduced the exposure of bupropion and its major metabolites in a dose dependent manner by approximately 20 to 80%. Similarly, efavirenz 600&nbsp;mg once daily for two weeks reduced the exposure of bupropion by approximately 55%. This effect of ritonavir, ritonavir plus lopinavir and efavirenz is thought to be due to the induction of bupropion metabolism. Patients receiving any of these drugs with bupropion may need increased doses of bupropion, but the maximum recommended dose of bupropion should not be exceeded.</p><p>Although clinical data do not identify a pharmacokinetic interaction between bupropion and alcohol, there have been rare reports of adverse neuropsychiatric events or reduced alcohol tolerance in patients drinking alcohol during bupropion treatment. The consumption of alcohol during <em>WELLBUTRIN XL</em> treatment should be minimised or avoided.</p><p>Post-marketing data show a possible pharmacodynamic interaction between bupropion and SSRIs and SNRIs resulting in an increased risk of serotonin syndrome (see Special warnings and precautions for use).</p><p>Limited clinical data suggest a higher incidence of neuropsychiatric adverse events in patients receiving bupropion concurrently with either levodopa or amantadine.&nbsp; Administration of <em>WELLBUTRIN XL</em> to patients receiving either levodopa or amantadine concurrently should be undertaken with caution.</p><p>Multiple oral doses of bupropion had no statistically significant effects on the single dose pharmacokinetics of lamotrigine in 12 subjects and had only a slight increase in the AUC of lamotrigine glucuronide.</p><p>Concomitant use of <em>WELLBUTRIN XL</em> and a Nicotine Transdermal System (NTS) may result in elevations of blood pressure.</p><p>Coadministration of digoxin with bupropion may decrease digoxin levels.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Digoxin AUC 0&ndash;24 h was decreased 1.6-fold and renal clearance was increased 1.8-fold in a healthy volunteer study.</p><p><strong>Interactions involving laboratory tests</strong></p><p><em>WELLBUTRIN XL</em> has been reported to interfere with the assay used in some rapid urine drug screens, which can result in false positive readings, particularly for amphetamines. A more specific alternative chemical method should be considered to confirm a positive result.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Fertility<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
mso-bidi-font-style:italic'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_1c868676-1d5a-4c56-af12-1ca9d4cf5704 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
mso-bidi-font-style:italic'><span style='mso-element:field-end'></span></span><![endif]--></p><p>There are no data on the effect of bupropion on human fertility. A reproductive study in rats revealed no evidence of impaired fertility (see Pre-Clinical Safety Data).</p><p>Pregnancy<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
mso-bidi-font-style:italic'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_3e02fc8c-5882-4f29-ba27-9e4d90611bae \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
mso-bidi-font-style:italic'><span style='mso-element:field-end'></span></span><![endif]--></p><p>Some epidemiological studies of pregnancy outcomes following maternal exposure to bupropion in the first trimester have reported an association with increased risk of some congenital cardiovascular malformations. These findings are not consistent across studies. The prescribing physician will need to weigh the option of alternative treatments in women who are pregnant or are planning to become pregnant and should only prescribe WELLBUTRIN XL if the expected benefits are greater than the potential risks.</p><p>The prospectively observed proportion of cardiac birth defects in pregnancies with prenatal exposure to bupropion in the first trimester in the international Pregnancy Registry was 9/675 (1.3%).</p><p>In a retrospective, managed-care database study (n=7SSSS005 infants), there was no greater proportion of congenital malformations (2.3%) or cardiovascular malformations (1.1%) associated with first trimester exposure to bupropion (n=1SSSS213 infants) compared with the use of other antidepressants in the first trimester (n=4SSS743 infants: 2.3% and 1.1% for congenital and cardiovascular malformations, respectively) or bupropion use outside the first trimester (n=1SS049: 2.2% and 1.0%, respectively).</p><p>In a retrospective case-control analysis using data from the National Birth Defects Prevention Study, there were 12383 case infants and 5869 control infants. A statistically significant association was observed between the occurrence of a left outflow tract heart defect in the infant and self-reported maternal bupropion use in early pregnancy (n=10; adjusted OR=2.6; 95% CI 1.2, 5.7). No association was observed between maternal bupropion use and any other type of cardiac defect or with all categories of heart defects combined.</p><p>A further case-control analysis of data from the Slone Epidemiology Center Birth Defects Study included 7913 infant cases of cardiac defects and 8611 controls. This found no statistically significant increase of left outflow tract heart defects with maternal bupropion use (n=2; adjusted OR= 0.4; 95% CI 0.1, 1.6). However, a statistically significant association was observed for ventricular septal defects (n=17; adjusted OR=2.5; 95% CI 1.3, 5.0) following the use of bupropion alone during the first trimester.</p><p>Lactation<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
mso-bidi-font-style:italic'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_1bd13661-cd28-4460-87cf-395d1eb2fe72 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black;
mso-bidi-font-style:italic'><span style='mso-element:field-end'></span></span><![endif]--></p><p>As bupropion and its metabolites are excreted in human breast milk, mothers should be advised not to breast feed while taking <em>WELLBUTRIN XL</em>.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As with other drugs which act on the central nervous system (CNS) bupropion may affect ability to perform tasks that require judgement or motor and cognitive skills.&nbsp; Patients should therefore exercise caution before driving or use of machinery until they are reasonably certain <em>WELLBUTRIN XL</em> tablets do not adversely affect their performance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The list below provides information on the undesirable effects identified from clinical experience, categorised by body system.</p><p><strong>Body (general)</strong>:</p><p>Fever, chest pain, asthenia.</p><p><strong>Cardiovascular</strong>:</p><p>Tachycardia, palpitations, vasodilation, postural hypotension, increased blood pressure (in some cases severe), flushing, syncope.</p><p><strong>CNS</strong>:</p><p>Seizures (see Special warnings and precautions for use), insomnia, tremor, dystonia, ataxia, Parkinsonism, twitching, incoordination, concentration disturbance, headache, dizziness, depression, confusion, delusions, paranoid ideation, panic attack, hallucinations, agitation,<strong><em> </em></strong>restlessness, anxiety, irritability, hostility, aggression, depersonalisation, abnormal dreams, memory impairment, paraesthesia, dysphemia.</p><p><strong>Endocrine and metabolic</strong>:</p><p>Anorexia, weight loss, blood glucose disturbances, hyponatraemia.</p><p><strong>Gastrointestinal</strong>:</p><p>Dry mouth, gastrointestinal disturbance including nausea and vomiting, abdominal pain, constipation.</p><p><strong>Genitourinary:</strong></p><p>Urinary frequency and/or retention, urinary incontinence.</p><p><strong>Hepatobiliary:</strong></p><p>Elevated liver enzymes, jaundice, hepatitis.</p><p><strong>Skin / Hypersensitivity</strong>:</p><p>Rash, pruritus, sweating.&nbsp; Hypersensitivity reactions ranging in severity from urticaria to angioedema, dyspnoea/bronchospasm and rarely anaphylactic shock.&nbsp; Arthralgia, myalgia and fever have also been reported in association with rash and other symptoms suggestive of delayed hypersensitivity.&nbsp; These symptoms may resemble serum sickness.</p><p>Erythema multiforme, Stevens Johnson syndrome, systemic lupus erythematosus syndrome aggravated and cutaneous lupus erythematosus, acute generalised exanthematous pustulosis and alopecia have also been rarely reported.</p><p><strong>Special Senses</strong>:</p><p>Tinnitus, visual disturbance, taste disorders.</p><p><strong>To report any side effect(s):</strong></p><p><strong><em>Kingdom of Saudi Arabia </em></strong></p><p><strong>-</strong><strong>National Pharmacovigilance centre</strong><strong> (NPC) </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reporting hotline: 19999</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail : npc.drug@sfda.gov.sa</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p><p>&nbsp;</p><p><strong>-</strong><strong>GSK - Head Office, Jeddah</strong><strong> </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel: +966-12-6536666</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email : saudi.safety@gsk.com</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: Thttps://gskpro.com/en-sa/<u> </u></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>GSK- Head Office, Jeddah</strong></p><ul><li>Tel:&nbsp; +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: gcc.medinfo@gsk.com17T</li><li>Website: https://gskpro.com/en-sa/<u> </u></li><li>P.O. Box 55850, Jeddah 21544, Saudi Arabia</li></ul><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms and Signs</p><p>In addition to those events reported under Adverse Reactions, overdose has resulted in symptoms including drowsiness, loss of consciousness and ECG changes such as conduction disturbances (including QRS prolongation) or arrhythmias; cases of fatal outcome have been reported. Serotonin syndrome has also been reported.</p><p><strong>Treatment</strong></p><p>In the event of overdose, hospitalisation is advised. ECG and vital signs should be monitored.</p><p>Ensure an adequate airway, oxygenation and ventilation. The use of activated charcoal is recommended. No specific antidote for bupropion is known. Further management should be as clinically indicated or as recommended by the national poisons centre, where available.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ATC Code<!--[if supportFields]><span style='font-family:"Times New Roman",serif;
mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi;color:black'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_8cb990dc-6983-4a1a-b109-12e05c33028a \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;color:black'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>Pharmacotherapeutic group: Other antidepressants, ATC code: N06 AX12.<!--[if supportFields]><span
style='mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
color:black'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_b726ec17-cc2c-43fa-85ca-9aa31d83a5d7 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
color:black'><span style='mso-element:field-end'></span></span><![endif]--></p><p>Mechanism of Action</p><p>Bupropion is a selective inhibitor of the neuronal re-uptake of catecholamines (noradrenaline and dopamine) with minimal effect on the re-uptake of indolamines (serotonin), and does not inhibit monoamine oxidase. While the mechanism of action of bupropion, as with other antidepressants is unknown, it is presumed that this action is mediated by noradrenergic and/or dopaminergic mechanisms.</p><p>In a study in healthy volunteers, no clinically significant effect of extended release bupropion tablets (450<strong><em>&nbsp;</em></strong>mg/day) compared with placebo was observed on QTcF interval after 14 days of dosing to steady state</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>Absorption</em></strong></p><p>Following oral administration of <em>WELLBUTRIN XL </em>to healthy volunteers, time to peak plasma concentrations for bupropion was approximately 5&nbsp;hours.</p><p>The absorption of extended release bupropion tablets is not significantly affected when taken with food.</p><p>Bupropion and its metabolites exhibit linear kinetics following chronic administration of 150 to 300&nbsp;mg per day.</p><p><strong><em>Distribution</em></strong></p><p>Bupropion is widely distributed with an apparent volume of distribution of approximately 2000&nbsp;L. Bupropion and hydroxybupropion are moderately bound to plasma proteins (84&nbsp;% and 77&nbsp;%, respectively).</p><p>The extent of protein binding of the threohydrobupropion metabolite is about half that seen with bupropion.</p><p><strong><em>Metabolism</em></strong></p><p>Bupropion is extensively metabolised in humans. Three pharmacologically active metabolites have been identified in plasma: hydroxybupropion and the amino-alcohol isomers, threohydrobupropion and erythrohydrobupropion. These may have clinical importance, as their plasma concentrations are as high or higher than those of bupropion.</p><p>Erythrohydrobupropion cannot be measured in the plasma after a single dose of <em>WELLBUTRIN XL</em>. The active metabolites are further metabolised to inactive metabolites and excreted in the urine.</p><p><em>In vitro</em> studies indicate that bupropion is metabolised to its major active metabolite hydroxybupropion primarily by CYP2B6, while cytochrome P450s are not involved in the formation of threohydrobupropion (see Interaction with other medicinal products and other forms of interaction).</p><p>Bupropion and hydroxybupropion are both relatively weak competitive inhibitors of the CYP2D6 isoenzyme with K<sub>i</sub> values of 21 and 13.3&nbsp;&mu;M, respectively. In human volunteers known to be extensive metabolisers of the CYP2D6 isoenzyme, co-administration of bupropion and desipramine has resulted in 2- and 5-fold increases in the C<sub>max</sub> and AUC, respectively, of desipramine. This effect was present for at least 7<strong><em>&nbsp;</em></strong>SS<strong>days</strong>SS after the last dose of bupropion. Since bupropion is not metabolised by the CYP2D6 pathway, desipramine is not anticipated to affect the pharmacokinetics of bupropion.&nbsp; Caution is advised when <em>WELLBUTRIN XL</em> is administered with substrates for the CYP2D6 pathway (see Interaction with other medicinal products and other forms of interaction).</p><p>Bupropion has been shown to induce its own metabolism in animals following sub-chronic administration. In humans, there is no evidence of enzyme induction of bupropion or hydroxybupropion in volunteers or patients receiving recommended doses of bupropion for 10 to 45 days.</p><p>Peak plasma concentrations of hydroxybupropion are approximately 10 times the peak level of the parent drug at steady state. The times to peak concentrations for the erythrohydrobupropion and threohydrobupropion metabolites are similar to that of the hydroxybupropion metabolite.</p><p>In humans, peak plasma concentrations of hydroxybupropion occur approximately 7&nbsp;hours after administration of extended release bupropion.</p><p>In a healthy volunteer study, ritonavir at a dose of 100&nbsp;mg twice daily reduced the AUC and C<sub>max</sub> of bupropion by 22% and 21%, respectively. The AUC and C<sub>max</sub> of the metabolites of bupropion were decreased by 0 to 44%. In a second healthy volunteer study, ritonavir at a dose of 600&nbsp;mg twice daily decreased the AUC and the C<sub>max</sub> of bupropion by 66% and 62%, respectively. The AUC and C<sub>max</sub> of the metabolites of bupropion were decreased by 42 to 78%.</p><p>In another healthy volunteer study, lopinavir 400&nbsp;mg/ritonavir 100&nbsp;mg twice daily decreased bupropion AUC and C<sub>max</sub> by 57%. The AUC and C<sub>max</sub> of hydroxybupropion were decreased by 50% and 31%, respectively.</p><p><strong><em>Elimination</em></strong></p><p>Following oral administration of 200&nbsp;mg of 14C-bupropion in humans, 87&nbsp;% and 10&nbsp;% of the radioactive dose were recovered in the urine and faeces, respectively. The fraction of the dose of bupropion excreted unchanged was only 0.5&nbsp;%, a finding consistent with the extensive metabolism of bupropion. Less than 10&nbsp;% of this 14C dose was accounted for in the urine as active metabolites.</p><p>The mean apparent clearance following oral administration of bupropion is approximately 200&nbsp;L/hr and the mean elimination half-life of bupropion is approximately 20 hours.</p><p>The elimination half-life of hydroxybupropion is approximately 20 hours and its area under the plasma drug concentration versus time curve (AUC) at steady state is approximately 17 times that of bupropion. The elimination half-lives for threohydrobupropion and erythrohydrobupropion are longer (37 and 33 hours, respectively) and steady-state AUC values are 8 and 1.6 times higher than that of bupropion, respectively. Steady state for bupropion and its metabolites is reached within 8 days.</p><p>The insoluble shell of the extended release tablet may remain intact during gastrointestinal transit and be eliminated in the faeces.</p><p><strong><em>Patients with renal impairment</em></strong><em> </em></p><p>The elimination of bupropion and its major metabolites may be reduced by impaired renal function (see Special warnings and precautions for use). In subjects with end stage renal failure or moderate to severely impaired renal function, exposure to bupropion and/or its metabolites was increased.</p><p><strong><em>Patients with hepatic impairment</em></strong></p><p>The pharmacokinetics of bupropion and its active metabolites were not statistically significantly different in patients with mild to moderate cirrhosis when compared to healthy volunteers, although more variability was observed between individual patients.&nbsp; For patients with severe hepatic cirrhosis, the bupropion C<sub>max</sub> and AUC were substantially increased (mean difference approximately 70&nbsp;% and 3-fold, respectively) and more variable when compared to the values in healthy volunteers; the mean half-life was also longer (by approximately 40&nbsp;%). For the metabolites, the mean C<sub>max</sub> was lower (by approximately 30 to 70&nbsp;%), the mean AUC tended to be higher (by approximately 30 to 50&nbsp;%), the median T<sub>max</sub> was later (by approximately 20 hours), and the mean half-lives were longer (by approximately 2 to 4-fold) than in healthy volunteers (see Special warnings and precautions for use).</p><p><em>Elderly</em></p><p>Pharmacokinetic studies in the elderly have shown variable results.<strong> </strong>A single dose<strong> </strong>study showed that the pharmacokinetics of bupropion and its metabolites in the elderly do not differ from those in the younger adults. Another pharmacokinetic study, single and multiple doses, has suggested that accumulation of bupropion and its metabolites may occur to a greater extent in the elderly. Clinical experience has not identified differences in tolerability between elderly and younger patients, but greater sensitivity in older patients cannot be ruled out.</p><p>Clinical Studies</p><p>The efficacy and tolerability of <em>WELLBUTRIN XL</em> has been examined in 7 double blind studies.</p><p>In one of two identical flexible-dose studies (WXL101497, n=576) <em>WELLBUTRIN XL</em> (150 to 300&nbsp; mg/day) was statistically significantly superior to placebo on the primary parameter, change from baseline in Montgomery-Asberg Depression Rating Scale the (MADRS) total score (p=0.006). Statistically significant effects were also found for a number of secondary endpoints including MADRS responders and remitters, Clinical Global Impressions (CGI) severity and global improvement, Sheehan Disability Scale, MEI and Q-LES-Q. The efficacy of <em>WELLBUTRIN XL</em> in this study was broadly similar to that of the comparator, venlafaxine. In the second study (AK130939, n=591), <em>WELLBUTRIN XL</em> did not separate significantly from placebo for the primary parameter, change from baseline in MADRS total score (p=0.146) although statistically significant effects were seen for venlafaxine (p&lt;0.001 versus placebo).</p><p><em>WELLBUTRIN XL</em> was shown to be of benefit in elderly patients in a placebo controlled flexible dose design study (AK130940, n=420) conducted over the dose range 150-300<strong><em>&nbsp;</em></strong>SSSSmg/day. Statistically significant effects were shown for MADRS responders, CGI global improvement, Sheehan Disability Scale, MEI and Q-LES-Q although only a trend was seen on the primary parameter, change from baseline in MADRS total score (p=0.085).</p><p>Two placebo and escitalopram-controlled studies (AK130926, n=424 and AK130927, n=425) over the <em>WELLBUTRIN XL</em> dose range of 300-450<strong><em>&nbsp;</em></strong>SSmg/day were conducted in adults. After 8 weeks of treatment, <em>WELLBUTRIN XL</em> subjects reported significantly less orgasm dysfunction than escitalopram treated subjects in each study (p=0.014 and p&lt;0.001 versus escitalopram) although statistical significance for <em>WELLBUTRIN XL</em> versus placebo was not shown for either study on the co-primary parameter, change from baseline in Hamilton Depression Rating Scale (HAMD) total score (p=0.179 and p=0.184 versus placebo, respectively). <em>WELLBUTRIN XL</em> separated from placebo on a number of secondary endpoints: mean change from randomisation in Hospital Anxiety and Depression scale total score in the individual studies; HAMD-17 remission rates in study 1; and CGI-S mean change from randomisation and CGI-I responder rates in study 2.</p><p>In an 8-week study of adult patients with major depressive disorder (MDD) and reduced levels of pleasure, interest and energy (AK130931, n=274), <em>WELLBUTRIN XL</em> showed statistically significantly greater improvement over placebo for the primary parameter, change from baseline in IDS self-rated scale (p=0.018). Statistical significance was also shown for a number of secondary endpoints including the clinician rated IDS, CGI severity of illness and CGI improvement.</p><p>In an active controlled 12-week study of <em>WELLBUTRIN XL</em> (300-450<strong><em>&nbsp;</em></strong>SSSSmg/day) versus venlafaxine in adult patients with MDD (WXL100368, n=348), <em>WELLBUTRIN XL</em> showed significantly less negative impact on sexual functioning (the primary parameter; p=0.005) and an overall efficacy similar to that of venlafaxine. <em>WELLBUTRIN XL</em> and venlafaxine were comparable as evaluated by the HAMD-17 total score, the depressed mood item, Bech melancholia subscale, HAMD-17 responder rates and the change from randomisation in the CGI-S. Statistical significance in favour of <em>WELLBUTRIN XL</em> over venlafaxine was shown for the proproportion of HAMD remitters and CGI-I responders.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Carcinogenesis/mutagenesis</strong></p><p>The oncogenicity studies in the mouse and rat confirm the absence of carcinogenicity in these species.</p><p><strong>Reproductive toxicology</strong></p><p><strong>Fertility</strong></p><p>There was no evidence of impaired fertility in rats at doses up to approximately 7 times the maximum recommended human dose (MRHD) on a mg/mPP<sup>2</sup>PP basis.</p><p><strong>Pregnancy</strong></p><p>There was no evidence of teratogenicity in rats or rabbits at doses up to approximately 11 and 7 times the MRHD, respectively, based on a mg/mPP<sup>2</sup>PP basis (the exposure at the high dose in one of the rat studies, 300 mg/kg/day, was 1.7-fold that in humans based on AUC values at steady state). In rabbits, a slight increase in skeletal variations (increased incidence of common anatomical variation of an accessory thoracic rib and delayed ossification of phalanges) was seen at doses approximately equal to the maximum human dose and above, and foetal weight was decreased at maternally toxic doses. At exposures up to approximately 7 times the MRHD on a mg/mPP<sup>2</sup>PP basis no adverse effects were seen in offspring of rats administered bupropion prior to mating and throughout pregnancy and lactation.</p><p><strong>Animal toxicology and/or pharmacology</strong></p><p>SSSSLiver changes are seen in animal studies but these reflect the action of a hepatic enzyme inducer. At clinical doses in human there is no evidence of any enzyme induction, which suggests that the hepatic findings in the laboratory animals have only limited importance in the evaluation and risk assessment of bupropion.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Tablet Core</strong></p></td><td style="vertical-align:top"><p><strong>Tablet Coat</strong></p></td></tr><tr><td style="vertical-align:top"><p>Polyvinyl alcohol</p></td><td style="vertical-align:top"><p>Ethylcellulose 100</p></td></tr><tr><td style="vertical-align:top"><p>Glyceryl behenate</p></td><td style="vertical-align:top"><p>Polyethylene glycol 1450</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Povidone</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Methacrylic acid copolymer dispersion (Eudragit L30 D-55)</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Silicon dioxide</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Triethyl citrate</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Edible black ink (for printing)</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The expiry date is indicated on the packaging.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 25&deg;C.</p><p>Store in the original package in order to protect from moisture and light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>White opaque high density polyethylene (HDPE) bottles containing a combination charcoal/silica gel desiccant canister and closed with a child-resistant closure that includes an induction heat seal membrane.</p><p>150 mg: 30 tablets</p><p>300 mg: 30 tablets</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None</p><p>Not all presentations are available in every country.</p><p><strong>&nbsp;</strong></p><p><em>WELLBUTRIN XL</em> is a trademark owned by or licensed to Sthe GSK group of companies.</p><p>&copy; 2024 GSK group of companies. All Rights Reserved.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Manufactured by:
Bausch Health Companies Inc.
Manufacturing Division, 100 LifeSciences Parkway, Steinbach, MB, Canada R5G 1Z7 

Packed by:
Glaxo Wellcome S.A.*, Aranda, Spain

Marketing Authorization Holder:
Glaxo Saudi Arabia Ltd.*, Jeddah, Kingdom of Saudi Arabia 
*member of the GSK group of companies

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Version number: GDS35/IPI19
Date of issue: 7 June 2024

            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>